MMTV proviral insertion sites and associated genes

Hasonló dokumentumok
Supplementary Table 2. Gossypol-induced Decrease of Levels of Reduced Cysteine-containing Peptides

Glyma10g15850 aagggatccattctggaaccatatcttgctgtg ttgggtacccttggatgcaggatgacacg AtMKK6, AT5g56580

Architecture of the Trypanosome RNA Editing Accessory Complex, MRB1

Akt1 Akt kinase activity Creb signaling CCTTACAGCCCTCAAGTACTCATTC GGCGTACTCCATGACAAAGCA Arc Actin binding

Nan Wang, Qingming Dong, Jingjing Li, Rohit K. Jangra, Meiyun Fan, Allan R. Brasier, Stanley M. Lemon, Lawrence M. Pfeffer, Kui Li

kpis(ppk20) kpis(ppk46)

Genetikai panel kialakítása a hazai tejhasznú szarvasmarha állományok hasznos élettartamának növelésére

Supporting Information

Apoptózis. 1. Bevezetés 2. Külső jelút 3. Belső jelút

Barangolások a peptidek és fehérjék világában

Az izomváltozások szabályozása a smoothelin-like 1 fehérje által. Tudományos hétfő előadássorozat. Lontay Beáta Orvosi Vegytani Intézet

T-helper Type 2 driven Inflammation Defines Major Subphenotypes of Asthma

Mozgás - Gyógyszer TÁMOP-4.2.2/08/

Extracelluláris vezikulák szerepe autoimmun betegségekben. Pállinger Éva

Jelutak. Apoptózis. Apoptózis Bevezetés 2. Külső jelút 3. Belső jelút. apoptózis autofágia nekrózis. Sejtmag. Kondenzálódó sejtmag

Új generációs sporttudományi képzés és tartalomfejlesztés, hazai és nemzetközi hálózatfejlesztés és társadalmasítás a Szegedi Tudományegyetemen

Trinucleotide Repeat Diseases: CRISPR Cas9 PacBio no PCR Sequencing MFMER slide-1

Vezikuláris transzport

pjnc-pgluc Codon-optimized Gaussia luciferase (pgluc) Vector backbone: JM83 pjnc-pgluc is resistant to ampicillin and neomycin High or low copy:

Biodízel előállítás alapanyagainak és melléktermékeinek vizsgálata állatkísérletekben. DOKTORI (PhD) ÉRTEKEZÉS TÉZISEI. Dr.

A posztszinapszis és a PSD (posztszinaptikus. szinaptikus plaszticitásban játszott szerepük

Table S1. Top and Bottom 10 most up- and down-regulated statistically significant transcripts (H 2 O 2 vs. untreated zebrafish larvae)

Növekedési faktorok és receptoraik a központi idegrendszerben

Supporting Information

Receptorok, szignáltranszdukció jelátviteli mechanizmusok

Tumor immunológia

Emlődaganatok gyógyszeres kezelés. Dr.Tóth Judit DE OEC Onkológiai Tanszék

Supplemental Table S1. Overview of MYB transcription factor genes analyzed for expression in red and pink tomato fruit.

Az orvosi biotechnológiai mesterképzés megfeleltetése az Európai Unió új társadalmi kihívásainak a Pécsi Tudományegyetemen és a Debreceni Egyetemen

Supplemental Information. Investigation of Penicillin Binding Protein. (PBP)-like Peptide Cyclase and Hydrolase

7. előadás: A plazma mebrán szerkezete és funkciója. Anyagtranszport a plazma membránon keresztül.

A jel-molekulák útja változó hosszúságú lehet. A jelátvitel. hírvivő molekula (messenger) elektromos formában kódolt információ

(AD) β (A ) (2) ACDP ACDP ACDP APP. APP-C99 γ (3) A 40 A 42 A A A A 42/A 40. in vivo A A A A

Bioinformatics: Blending. Biology and Computer Science

CzB Élettan: a sejt

Suppl. Materials. Polyhydroxyalkanoate (PHA) Granules Have no Phospholipids. Germany

3. Főbb Jelutak. 1. G protein-kapcsolt receptor által közvetített jelutak 2. Enzim-kapcsolt receptorok által közvetített jelutak 3.

A sejtciklus szabályozása

tccattaattcgacagaccagagttaaataatccttgtatgccattgtgatcacatctacagttcagattttgtatttca

Az orvosi biotechnológiai mesterképzés megfeleltetése az Európai Unió új társadalmi kihívásainak a Pécsi Tudományegyetemen és a Debreceni Egyetemen

MikroRNS-ek szerepe az autoimmun és reumatológiai kórképek kialakulásában

ONKOGÉN K-RAS MUTÁCIÓK: SZERKEZET ALAPÚ ALLÉL SPECIFIKUS INHIBITOR TERVEZÉS. Vértessy G. Beáta MedInProt Konferencia Budapest, április 22.

4,5 napos egér. 6 napos human. 8 napos human 10 napos human

Az Oxidatív stressz hatása a PIBF receptor alegységek összeszerelődésére.

A posztszinapszis és a PSD (posztszinaptikus. szinaptikus plaszticitásban játszott szerepük

Expressziós microarray. Dr. Győrffy Balázs

Anyák idegrendszerének adaptációja, mint a komplex viselkedések szabályozásának modellje

2. A jelutak komponensei. 1. Egy tipikus jelösvény sémája 2. Ligandok 3. Receptorok 4. Intracelluláris jelfehérjék


Bevezetés Áttekintés

Immunológia alapjai előadás MHC. szerkezete és genetikája, és az immunológiai felismerésben játszott szerepe. Antigén bemutatás.

SOLiD Technology. library preparation & Sequencing Chemistry (sequencing by ligation!) Imaging and analysis. Application specific sample preparation

Receptor Tyrosine-Kinases

Supporting Information

I/A. Az alkalmazottak adatai

Membrántranszport. Gyógyszerész előadás Dr. Barkó Szilvia

2011. október 11. Szabad János

A doktori értekezés tézisei. A növényi NRP fehérjék lehetséges szerepe a hiszton defoszforiláció szabályozásában, és a hőstressz válaszban.

Mapping Sequencing Reads to a Reference Genome

Mapping out MAPK interactors

A sejtek szilárd környezete A sejtadhézió és sejt-vándorlás alapjelenségei

A B C D EF C D EF C C BF A BC DE F D A E E E E D C C E DC C E E DC C C E D D E A D A E A

Autoan'testek vizsgáló módszerei, HLA 'pizálás. Immunológiai és Biotechnológiai Intézet PTE- ÁOK

Fehérjeglikoziláció az endoplazmás retikulumban mint lehetséges daganatellenes támadáspont

Hormonok hatásmechanizmusa

Jelutak. 2. A jelutak komponensei Egy tipikus jelösvény sémája. 2. Ligandok 3. Receptorok 4. Intracelluláris jelfehérjék

A veleszületett (természetes) immunrendszer. PAMPs = pathogen-associated molecular patterns. A fajspecifikus szignálok hiányának felismerése

Seven gene deletions in seven days: Fast generation of Escherichia coli strains tolerant to acetate and osmotic stress Supplementary Figure S1.

Nagy áteresztő képességű SNP mérések hasznosítása. Dr. Szalai Csaba

University of Bristol - Explore Bristol Research

Főbb jelátviteli mechanizmusok a fejlődés során

Mai témák. Fehérjék dinamikájának jelentősége. Számítógépes modellezés jelentősége

Receptorok és szignalizációs mechanizmusok

A mutáns fenotípushoz szorosan kapcsolt markerek (1N1R és U212D) segítségével BAC (Bacterial Artifical Chromosome) klónokat azonosítottunk egy másik

MATEMATIKA GYAKORLÓ FELADATGYŰJTEMÉNY

V. Gyakorlat: Vasbeton gerendák nyírásvizsgálata Készítették: Friedman Noémi és Dr. Huszár Zsolt

Tézis tárgyköréhez kapcsolódó tudományos közlemények

XLVI. Irinyi János Középiskolai Kémiaverseny február 6. * Iskolai forduló I.a, I.b és III. kategória

Immunológia alapjai. 16. előadás. Komplement rendszer

- Csatornák pumpák - Ellenállás kondenzátor komponens - Fordulási-, membrán potenciál. ellenállás. kondenzátor

Gene Refseq ID Supplier ID Oligonucleotide sequence Seed Freq HITS Seed Freq LIB p-value mirna matches %3'UTR Gene removed

Szövettan kérdései Ami a terápiát meghatározza és ami segíti Dr. Sápi Zoltán

Az idegsejt-felszín specializált membrán-foltok mozaikja

Immunmoduláns terápia az autoimmun betegségek kezelésében. Prof. Dr. Zeher Margit DE OEC Belgyógyászati Intézet III. sz. Belgyógyászati Klinika

KUTATÁSI TÉMAJAVASLAT ITC hallgatónak jelentkezők számára ROP GTPÁZOK ÁLTAL KÖZVETÍTETT JELÁTVITEL NÖVÉNYEKBEN

Sebastián Sáez Senior Trade Economist INTERNATIONAL TRADE DEPARTMENT WORLD BANK

Supplementary Table 1. Cystometric parameters in sham-operated wild type and Trpv4 -/- rats during saline infusion and

Az F# nyelv erőforrásanalízise

Új temékek az UD- GenoMed Kft. kínálatában!

Az immunválasz genetikai szabályozása. Falus András Semmelweis Egyetem GSI Intézet

AZ ÁRPA SZÁRAZSÁGTŰRÉSÉNEK VIZSGÁLATA: QTL- ÉS ASSZOCIÁCIÓS ANALÍZIS, MARKER ALAPÚ SZELEKCIÓ, TILLING

Nyitott!kérdések. OMIM-SMPD1, imprinting SMPD1:

Xenobiotikum transzporterek vizsgálata humán keratinocitákban és bőrben

A cell-based screening system for RNA Polymerase I inhibitors

A zsírszövet mellett az agyvelő lipidekben leggazdagabb szervünk. Pontosabban az agy igen gazdag hosszú szénláncú politelítetlen zsírsavakban

Szignalizáció - jelátvitel

Növekedési faktorok és receptoraik a központi idegrendszerben Dobolyi Árpád

SUPPLEMENTARY INFORMATION

A koleszterin-anyagcsere szabályozása (Csala Miklós)

Immunológia alapjai előadás. Immunológiai tolerancia. Fiziológiás és patológiás autoimmunitás.

Átírás:

Supplementary Table 1 (Theodorou et al.) : MMTV proviral insertion sites and associated genes Tumor Nr Gene ENSMUSG Sequence 11 1110012J17Rik ENSMUSG00000052105 GGCCGCTCTCCAATCTGAAGGAGTNAGGACAGGTG CTCGGCCAGNGAGAACCTGTACTTGGACGCTTTGT CCCTGGATGATGATC 6 1110059P08Rik (CF55; gene of unknown function) ENSMUSG00000019868 GNTCAACGTCTGGTCNTTCAGGGTGTTANCGCTTG TCTCGGNCTGTTGTATTGCTTCCTCACTGNGGATTN TGTGTAGCCTGCGGTTCTNAGGNACAAAGTACTCT CTGCAGGCCACCTCTCCTCTGCACGGGGGAAGGA CAACAGNATGTCTGGAGCTCACATCTATTCCGGTCT CTCCTAGAAACGGNTTACTCTA 171 PT 1110067M19Rik ENSMUSG00000056643 CCTTAGAGGCTTCNTCGAGCAGTGAGGCNGTCAGC TTTACTAACCTTACTACTGNCCTCATGGTTTCTGGC TGCTTTGAACTCTCCTTGAGCACCTTGNGAAGCTGA GTTTCTGATTTCAGCTGCTGGATC 137 PT 1300010F03Rik ENSMUSG00000058997 GGTTCATGTCTGCGTTGCGCTTCAGANNANTACTG CTGTCATTGTNGAAGATCATAGCATTACNTTGCGGA NATCGNTTAGCGTATNTCNTGTGTCCTTATCCTNGC ATATCNGTNNNANNCNGNCNCNNNCNAACACNNAN NGCNTGNGNCCACGGTTCCCCTCCTAAGCAGACGC AGTACTCNAGAGACGACCCACCCATTGGTCAGGAT C 150 PT 1300010F03Rik (Q8CC88) peptidase ENSMUSG00000058997 GTTCATGTTGGAGAAACGCTTAGANAATTATCTGTC TTTTGTTGTCTAAGAAGAATAGGCGCATGGGAGGG GTGTCCTTTCCTTTCCTTGAATTTTCCCCACTGGGC TCCCTAAAACAGAATGGCTGTGCACACAGTCCACA CAAAGAGCACAGCACTCCAGAGACGACCCACCCAT TGGTCAGGATC 18 1600014C23Rik ENSMUSG00000035411 TGNACCAAGGAGTTCTCACGTGAAGCTTNTCTGCG CCTCCGTGGATGGCGCTCTAAACTTGCNTCTTTGN NAGNACCAGCGANTGCGCACATATGTACACTCACA AAGATCCCATCGATGTCAACACCAGTCTTATTNAGC CACGGTCTCTCCTAGNAACGGTTACTCNA 104 1700009P03Rik (NM_134077:cutaneous T-cell lymphoma tumor antigen se70-2 ENSMUSG00000022119 GTCCAGCATCAAGGATC 83 1700011K15Rik (NM_029294:similar to phosphoribosyl pyrophosphate synthetase 1-like 1) ENSMUSG00000046292 CCAGGGCATGGTGATGTCTGNNNTTCATGCTGNTG CTGAAGACCATGTCNGGNTCCATAATCTTGCCNTG GCTTGGTCAATGTTGACATATGTAGCCCACACTGC CACCGAATGCAGGGCAGGTGTACATGTTTTATGCC AGAAGCCATGCTGATATCTATGATC 130 PT 1700017G19Rik ENSMUSG00000037884 GCTTAAAGCACAGGCTGCATANNCGGATGCTGGAA TCCAGCGCCCTCAGCTTCGTTAATCAAAGTAATTGA GATGAATGCATACTTCAGAGATGGTTGATAATAATA GTTCTGAAATCAAGCACAAGAGCCCGGAAGACTAC ATTTCAAAATGTAAACACTCCGATGCACCCAAACAT TCACAGCGGGGAGTTTGAAGTCANCTATGTATGAA CAAACAG 33 1700029M20Rik (ADULT MALE TESTIS CDNA PRODUCT) ENSMUSG00000028802 GGGGACTTTAATTACTTCAACTACCTGACCCTCAGC TGCCACATCTGTCCACAGAAACGAATATGCCTCATT CCCAGGAGGCCTGTGAGGAGTGGAAGGATGGCAT CTGAGGAGGCTTCAGCACAGGAGCCATCAGTTGTA GCAGGGGCTCTGTGGGATCACATGGGCATTGCTAC CTGA

55 1700049L16Rik (NM_175390) ENSMUSG00000043859 TCCCATCCACGTTGATC 76 1700060H10Rik (MALE SPECIFIC LETHAL 3 1 MSL3 1 MALE SPECIFIC LETHAL 3 HOMOLOG 1) ENSMUSG00000047669 AAGCACATGGCTAGCACTGATCNGCTGCCATTTCG TCCAGTGCTACTGCCAGAATGCCACACTTGTTGAG ATC 191 PT 1700081L11Rik (Q7TMU3) ENSMUSG00000018412 CTTTGGACTGTCAGTGTGGCCNGANCATAGTAAAC AAAAAGTTTAGTGTGTTTCCTAAAGATCCAGATACA GGCAGGAACCAGAGCAGGTAGGAACTTTGTGGGC CATGATAAGGAATGCAGAAAAGGGGATTTTAGCTA TCCCTGAAGTAGTTACTGTGTCTAACATGTGTGGTA TTGTGATC 72 1700112E06Rik (CJ11_MOUSE):novel with Immunoglobulin/major histocompatibility complex domain ENSMUSG00000063458 AGCACGTATAAGTATCTGATC 71 1700112E06Rik (CJ11_MOUSE):novel with Immunoglobulin/major histocompatibility complex domain ENSMUSG00000063458 GCCGACATTCTTTTCTACAAGTAGGAGGAAGAGAG AGCTTGTTGAGAATAAATATGGACGTTGGAAATCTC CAAGCCTAGTGACATTTCTTCCAAGAAGGCCACAC CACCTGATC 110 2410017I17Rik ENSMUSG00000038311 AGGTACNTTGTGTGAATGTTTCTCT 170 2510010F15Rik Ubiquitin conjug enzyme ENSMUSG00000026307 TGANGANGNGCTNAAATGGTGTNCCTGGCCNGANN ANGGNCTCAAACTTGCTTTCTGAAGACCAGGATGG CCGTTGAACTCACA 43 2610018I03Rik (Q9D0H0) ENSMUSG00000032415 GCAACCTAGGTCTTGGATTG 11 2610036F08Rik: zink finger prot 103 3000003F02Rik (NM_172437) TruD domain containing gene (t RNA modifier) 7 3110001D03Rik (NM_025849 ) ENSMUSG00000023892 GAGCAGGACGTGANGAGGCTCTCTTTTACTGCTAA TAAGGACGCCAGATCCCATCGATGNCGACNCCAGA CTCNTTCNCCACCAGACGGATGAGCCCATNANAAC AAAG ENSMUSG00000033356 ATCCTTCNCGGTGCCTACAAGAGAGNCCNCCACAT TCAGCTACACAGNAACCNTTGCAGATAAGAAGAAT CAAGANCGNGTNCAAGATC ENSMUSG00000028398 GTCTGCCCAAACTGGTCTTCAGTTGAAGAACTCTGT TAGTTGACCTAAATCTGTTTCTAAAAGGCCAAAGTT CATTCTGATC 14 4921507L20Rik ENSMUSG00000027196 GGCACCCAGTTGAGATTCTTTTGCTCTTTACTTGAG CCTGGGTGTGTGATC 182 PT 4930449E01Rik (Q9D5E5)MUS MUSCULUS ADULT MALE TESTIS CDNA PRODUCT 173 PT 4930451E13Rik pathched related family 9 ENSMUSG00000022116 TGATAATGGACTAAACCTGTGANNCCTAAGTCAGCT ACGATTAAATATTTTCCTTATATAAGAGTGGCCATG GNCATTGNATATCTGTACAGCAATCGGACACTAAG ACAAGCAGACAGACCANGTTTAAGCACTGGCAAAT ACATTATTTTTCCTGACCGTAATAGATTACGTTTACT GCAAATCAACTGTTGCATAATGATC ENSMUSG00000039198 GTGCCCATGCACACTTTGTGTGNGGGGAANNNGTN CCANCCACTGGGCCGCCCANGTCAGAAAGGTTNAC TTTATGCATCCCACCTGNAGTAGTATTCTGCGCTAA GCTACAGGGTGATAGCNGAGGAATGCGCCATAGG CGGAGCGTGAGGTAGATGCTCTGTGCCAAGGACT GATC 166 PT 4930451I11Rik ENSMUSG00000045989 TGTGGGGTGGCACAGACACACCAGAAGAGTGCAC CTGGATC 49 4930481F22 Rik ENSMUSG00000033409 CACTGCTGATGCATCTAGGGCCAGTCAGACGGCTC TGCAGATAAAGGCACTCAATGCTAATCCTGGTGAC CAGAGTTCAATCCCAGGAACCCACACTGTGGAAGG AAAGATCAAAATTCAGGTGACAGCAGATGCTGGCG AGGATGTGGANAAAGAGGAACACT

70 4930485D02Rik (TAS1_MOUSE: Threonine aspartase 1, Taspase 1) 15 4930544G11Rik (Rho related GTP binding; NM_026294; Ras GTPase superfamily) ENSMUSG00000039033 CCTCGGATGTTCGCATCCCGTATNCTCTTGCCCNC TGNGTNNNCTCCAGGTCAATNGGTTCANTNNNAAT TATTATCTGACGCACTTGTANCANCTCANNNNTGAG ATAATGNATCGTGNNTACTCTGTGTCTTATNCTGNT CCCATCGATGTCAGACACCTAGTCTCATTCAGCCA CGGTCTCTCCTAGCAACGGTTACTCTA ENSMUSG00000036463 ATCATATGTTCAGCCCCCNTCGTNNTGAGTGGCAG AACCTACCCTCCCTTTTCAAATTCNTATAACCTAGG AAATAGTATCCTCTCTAAAGAAAATNCAAAGAGTAG AGCAGAGTACTGATAGTCCACACCATTCAGAGACT GCCCCACCTGGTGATCCCATCGATGTCGACACCAG TCTCATTCAGCCACGGACTCTCCTAGCAACGGTTA CTCT 60 4931429L15Rik ENSMUSG00000056617 GACTCAGAATACATGGAACATGAACCTGGNGTTTG TTNAAGCTAACGTNGGAACTCAGGCCTGTCTGATC 71 4933415L06Rik ENSMUSG00000034795 TCCAGTGTTATTTTGACTATGGCAGGNCCTGATC 17 5133400D11Rik ENSMUSG00000030259 GGCCTCAGAGGGTGTGAGGGAAAAAGTGTCTGGTT ATAGGGAAATTCTTAATACTGCCTCTTGTTACAACA CCCTGGAGGGAGGTAGCTGGCCCACCCTCTTCTGT CATTTAGTACCTGGGACTCCACATTTGACATACTGT TAGCATGGCCNGATC 19 5430433E21Rik ENSMUSG00000054978 GGTGGGTCTGCNNATTTATCCTCGGGGTCTANATC TGTGTCCTAACAGGGTTACAGGAGTCTCTTACCCTC CTCCTGCTGCCTTTTTGGTAATGCATAGCTGTTCCA CCACNNTCCCCAAACCAGGAGCCAGATGAACACTT CCCACACAGATACACCATCCTATCAAAGCCTGGTC CCCAGAGTGAAGTGGAAGGAGAAGGCAGTCATCAA ACTCCTTTTCATCTGACATCTTGGGACCGAGTATTA GATGGTCAACCAGGAAAGCTGTGGACAGTTGGAAA AGTACCAGGGCTGCAGGAGAGCCTGGGGCTGTCT CTCCTAGCAACGGTTACTCTA 94 5530400C23Rik (SUBMANDIBULAR GLAND SECRETORY GLX RICH PRECURSOR GRP ENSMUSG00000055594 CAAAAATGCTCATTTGGAAACATATGTGCATATTCT TATTATCTTATTGTTATATCTGTATGGATATTTCACA TGGAACAAGTACTTTTGCAGAGTGATGACAAAATTA TGGAAACAATTTAAATTTCCTTATTAGTATTCTGAAA ATTTTTATATTATCAGACATAACTKGATC 118 1110002B05Rik ENSMUSG00000044408 CTTTATCCCAGATGAAAGGCG 136 5730409F24Rik (NM_181403 with Molluscan rhodopsin C- terminal tail) 82 5730522E02Rik (Q9CYD8/Q8C4V9 ) 11 5830415F09Rik prot with unknown function ENSMUSG00000048832 GGGTCCTGAATGTGGTAAAGCCCNCTTAACCATGT ATTTCAGATACTAGAGATC ENSMUSG00000032985 AATCTTGGGTGNGTATATTTGTNTGAAGGCGNAGC TATGAATTCCATCTTGNAGTCAAAAAATGTATGTCA TCAGTAGGAATTCAAACCTAGCCAATAGCTGAAGG ACTGATGGTGCTCGTTCCTTANCAGCCATTTTCCAT CGATGTCGGACACCGGATCTCANNCAGCCNCGGG CCCTCCANNAAACGGTCACTCAA ENSMUSG00000028331 TAGCTTCAAGCAATTGCCAATAGAGTCTGTGACTCT ACCCCAGTAAGAAGAAACTTGACCATTACCAACCTA CCTCTGCTCAAAACAACTCGGGGAGGGGTAGAAG GAAATGTTTATATTGCTTTGATCCAAATGGGTAAAC TTTGTCAGAATTTTGTATCATGAGTAGAACCCTCAC CCTATGGGGTGTAGGAGTACATCATCTGAATAAAAT TGTATGCAGTAAAATTCAGGACTCTTA 9 60S ACIDIC RIBOSOMAL P1 ENSMUSG00000060910 CACATTGGTTGTTTGTCCAATCTTATGCGTGGTGGC CAGCAGTAGTCAGTGCCACTCAGCAACGGCACATG TGGCTTCCCACAAATATATCTGGGTAGACGGCTTG TGATC

32 6330442E02Rik (NM_177872, ADAMTS PRECURSOR A DISINTEGRIN AND METALLOPROTEINASE WITH THROMBOSPONDIN MOTIFS ADAM TS) ENSMUSG00000043635 TAGTCTATTTGTTTTAGGAAAGAGCAGTAAATGTAN CATTTCAAAGGNTTTATAGCACCATGGATGTTGGG GAACAGTGTGTTGATC 49 6330500D04Rik (Q8BJ19:unknown with Histamine H3 receptor domain) ENSMUSG00000036006 AGGCCCTCTGCACACATGTTACAATTGTGTAGCTTG ACCTTCTTGTGGGACTCCTAACAGTGGGAGAAGGG GCTGTCTTTGATTCCTTTCTTGGCTTTTGGGACCCT TTTCCCTCATGCTGGATGATC 144 PT 6530411B15Rik ENSMUSG00000035413 CATTGCATGNACGTATTCCGAGATGTCNGGGTTTA CAGGATTAGCACTGTCATCTGTTCTCTNATTCCCTA AGCCNCGTTTTCAGTGTTTCTGTCTGATCTCGCTTC TCTCACTAATGTCACAGACACTGTCTCCCNGTTCCC ACCCTTTCTAATTCATGATAGGATTGAGTATTTCTA GTATATCTAGCATTGATCAGGATTTGGCCCAGAGTA GCACTCTGGTCATCCTTAGGAAGGTGGAACCCAAG CATTAGGCACCTCTACTAGAAGTTTAGGATGGGAC TTAANGTTCTGANCTTTAATAGCAGCATCCCAGAGA TC 11 9030221C07Rik (NM_177802) LARGE NEUTRAL AMINO ACIDS TRANSPORTER SMALL SUBUNIT L TYPE AMINO ACID TRANSPORTER 41 9030611O19Rik (= NM_027828) ENSMUSG00000020600 GCTCTGATTAATAAATCCCTTGGAAGTTCTGAATAT GCTGTGCAGCCAGCGTGTCTGATC ENSMUSG00000036136 GTTAGCACCTATAAAACTGTTAATCCATGGNAGTTA GTTTTAAGGAATCCAAATTCCTTTCTAAAATAGAAC AACTGAGTTCCATATAGATGGAATCTGTGCAGGAG AGCAATGGACACTGCTAGGTCATTGATC 71 9030625A04Rik ENSMUSG00000044350 TCCAGTGTTATTTTGACTATGGCAGGNCCTGATC 14 9130008F23Rik (unknown gene ) 62 9130221D24Rik (family of DYNAMIN BINDING SCAFFOLD TUBA with a Rho gef) ENSMUSG00000054951 GGGTCAGAGGTTCAGCCCATTATCATCAAGGTAGG AGCATGGCAGTGTTCAGGCAGACATGGGGATATAG GAGCTAAGAGCTCCACCTGTTGATC ENSMUSG00000056559 AATTANCTTTGTTTTTGTCCTTCATAACCCAGGAAA CACCTAACTTTATAGAAGCTTTACTTTCTTAAAT 8 9330164H19Rik ENSMUSG00000043671 GGGTTCACGCCTTCATGGTTGCTTGCCAGCAGTGC CTTAGCTATGGTGTTTCCGCTGATCAGTTATGTCAT GGCTGGCAGCATGAAAGTCTCCAACAAAGGCAGAA TGCAAGAGGCGGGCCAGCTGGGCAGTCTCTGACC CCAGCAGCTGTAGNGGAACGCTAGATTGCTTGGTT GGGACTTCTTGTAGCTAGGAAGCTTCTGCAGGGCA AGTGTGTTAAGCTCTTCCCTGACCTCTTTACTTCTG GNGTTTTGCTGTATAAGCTTTCAAACAGAGCAATGG ACTCCCGTCCACATAAACTCAGGTGTGAGCAGTTG ATTAGTGATGACAGACCTGAGATCCCATCGATGCG ACACCAGC 70 9630041A04Rik ENSMUSG00000057710 GGAGCTNTGGAGCCGACTTATGTCTCTCCTAGCAA CGGTTACTCTACGGNCNCTNCTAGCAACGGTTACT CTACGG 182 PT A930004K21Rik ENSMUSG00000027238 AATTCATACCCTCAATTCTGCCATGCACATTATAAAT TTCATTATTGTCTTCCTGTTGATTTANAATTCACTGA TTATTTT

49 Abca4 (ATP-BINDING CASSETTE, SUB-FAMILY A, MEMBER 4; ATP-BINDING CASSETTE 10; RIM PROTEIN; RETINOBLASTOMA BINDING PROTEIN 2-RELATED) ENSMUSG00000028125 CCTCTGGGATAAAAAGGCCAAGCAGCTCCGCCCTC AAAATGCTCAGATGAATTAACAGATTAAACAGCGAA GAAAAAAAATAATGCCGTCCGCAGCGTGGTGATGA GAGACAGACCGAGCGGTGGTGACAGCAGCCTGGC ACCACGACGA 64 Acacb:acetyl-Coenzyme A carboxylase beta 187 PT Acsl4:Long-chain-fatty-acid-- CoA ligase 4 (EC 6.2.1.3) (Long-chain acyl-coa synthetase 4) (LACS 4) 109 Act16a 53 KDA BRG1- ASSOCIATED FACTOR A (ACTIN-RELATED PROTEIN BAF53A) ENSMUSG00000042010 CTATGAGGTAACGGACCTTCTCTTCATACTGGGAAT ATGATTTAGGAGTAAGGTTTGTATCTCTGATTTTGC AGCGGGATTGGCTTCCTTCCTCGGATCCTCCCTCT ENSMUSG00000031278 TCCTCCAANTTTGANTNTNTANTGACAAGAGTCACT GACATGTGTTTGTTTCCAGGATAANCAGGATC ENSMUSG00000027671 CCTCACATCACCCTGGCACCATTGCATGTGTTCTTG TGTGTTTCCCACAGCTGGGTATACTGCAGG 76 Actn1:actinin, alpha 1 ENSMUSG00000015143 CGTGCATTTGCCAACTCTANCTAGGAAAAGCTCAG AGCTGGAGAGATGGCCCAATGAGACCACTCGTTCC 171 PT Adamts10 ENSMUSG00000024299 GAGCTCTGTCTGGTTGTTNGTNTGTAGCCCATGCC TATCCTGAGAACTCATAGAGATCTACTCGACTGCG CCCACACACAAAGGTCTCAGAGCAACACTTTGGCA AGAGGGGGCAAANANTTATATAAAAGCCAGAACTT CAGGGAGTTTGATC 2 PT Adamts12:ADAMTS PRECURSOR A DISINTEGRIN AND METALLOPROTEINASE WITH THROMBOSPONDIN MOTIFS 49 Adamts18:a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif 92 Adcy2:ATP PYROPHOSPHATE LYASE ADENYLYL CYCLASE 92 AI851790 (chemokine (C-C motif)-like), member A2 27 AI852640 (expressed seq) or C330021A05Rik Rab related gene) 11 AIP; AH receptor-interacting protein//nm_025889 ENSMUSG00000047497 GGGCTATGCTAAAGAGTGNAAGGATTANGCCNTGA GTAGGTGGATAGTTACNATTTTAAGAAACTGGNCAA GCTGTTCCTATCTATGTTGAAATTTTNGTATCCCTC CAAATTGNAAGTTGAAATCCTAAATCGGTATGTTGC CAGGAGGTGTAGGCCTTTGCNNAGCTCAACCTTCN CAAAGGGAATGANGAGACCTTANAACCTGGCTCCT TATGGCAAGGAAANANGGACTGACATCGTCAAGNA AGCTGGTNAGCNANG ENSMUSG00000053399 CACTGCTGATGCATCTAGGGCCAGTCAGACGGCTC TGCAGATAAAGGCACTCAATGCTAATCCTGGTGAC CAGAGTTCAATCCCAGGAACCCACACTGTGGAAGG AAAGATCAAAATTCAGGTGACAGCAGATGCTGGCG AGGATGTGGANAAAGAGGAACACT ENSMUSG00000021536 AAATTGGACTGACTCTTGACCCATTGGCTTCTGCAT AGGTAGGTGCTGTCTCTATGCCCCAACCATCGATG TCG ENSMUSG00000044071 GTCCATCCTGAGTCATTTCTTCCTGCCGTTAGAACC AACGTAGACTGAAAACAGAAAGCTATCTACAACATC CTTGGGTC ENSMUSG00000020658 GTATACCAGAATCTATCGCCTANNGGATCCGGGGG TCTCTCCTAGC ENSMUSG00000024847 GCNTGCNGGCNCTCAGNCAGCAGNNACACACACA TGCGCGNACGCGCGCACACACACATACACACATAC NCACACACACNCACACNGACNCTGTTTNTAAAGAG TAGGCCTGGATAGTATGATATCTCCCCGGCAGGTG AAANGCCCTGGGCTCAGTCCTCAGCCCNAGGACAN ACANAACACTGGGAAGATGGAAACTGAAGACTTAA CCTTAGGAAAGATGTAAGGATGATGGACTCCCATT GCCCCTGCTCTCGGCACACAGTAAATTACTAGCAG ACATTCATATGCGGATGGTTTTGGACAAAGGNTTTN GGGTTGCTCCATTTGGAAATGAGAGGTAAGAAAAA GCCAGTTCCCATCATGTGTGGGTACAACTAGACAG AAGACCAGATCCCATCGATGTCGACACCAGTCTCA TTAGGCC

153 PT AK220484 ENSMUSG00000042942 CCTGAGTCCCCCACTGGTCCCAGNNACTCCTGGTA TTGGGGTAGATGTATCTTCCTCACCTATGATC 95 Aldh1a7 ENSMUSG00000024747 GCCTGTGCATTTACGTGTGGT 14 Alkbh3 ENSMUSG00000040174 GGCACCCAGTTGAGATTCTTTTGCTCTTTACTTGAG CCTGGGTGTGTGATC 111 Als2cr19 in intron :amyotrophic lateral sclerosis 2 (juvenile) 71 Ap4m1: Clathrin adaptor complex, medium chain 94 PT Aqp4:Aquaporin 4 (WCH4) (Mercurial-insensitive water channel 4 Arf3; ADP-ribosylation factor 3 (or Wnt10b) 109 Arf3; ADP-ribosylation factor 3 (or Wnt10b) 95 Arhgap6 :RHO GTPASE ACTIVATING 6 66 Arid3b:DEAD RINGER 1 B CELL REGULATOR OF IGH TRANSCRIPTION BRIGHT ENSMUSG00000052062 GTTCAGGGTCTGCTGCTTCTCCACGGGGTNCGTCN GNGGTGCTACCAGGTGGATC ENSMUSG00000029730 AGGACGGCGANCAGACTGACTGGATTCGATTTCTA CCCAGCTACCCTACCCCGTCTCCCGGGTCAAAGGA TNCAGTCTNTATAGATGANGGATC ENSMUSG00000024411 CTATCCCCCTGACTGTGGGAGNNCACTCCCCCGAT CATGGAGTCTATCCGCCGCATCATGAGTCTATTCAC CTGATCATGAGT ENSMUSG00000051853 GCGTCTCCTCCTCGNACNNNNCAAACCCGGCGGC AGGTGNGTGTCCAGGNCTTTCACCCAGCGAGCCCA AGGCCCCTTGACTCCCACNGCCAGGATGATC ENSMUSG00000051853 GCAGAACTACTAAGGGGAAAAG ENSMUSG00000031355 GGAGAATAGTCATGCGGGGatc ENSMUSG00000004661 GCATTATTCAACTGACATGTNCNCCCNCCCNGCAT GTGANNANAACTGATCCTTCATTCTCGGCATCNNTT ATGACAAATTTTTGNTTGCTTGCCAAGTTGCACAGA ACGTGTAAGTAAATTCTGGATGGCACNGTAGATGT CAGAACGACTAGATCACATAGATGGGAGTCGGCAT GAGGGGACTTCTGAGTTCTTGTGAAAAAACTGCAA GAAAACAAAAGTCTTGTGACCTCAATTTCTTAAAAG AAACAAGGAATTATTCTTGGGATGTGTTTTAGTGCT GATC 12 Astn2 ENSMUSG00000028373 CTCCCGGCATGTTCAATCTTCCACTTCAGGTCTCTA GNAAGcACCAGCTCGAGAGTGTAGGTGCTGGTTGC CGACCGGGGCAACTATCGTATACCAAGTGTTCAAC CGCAAAGGCTTTTTGAAGGTGATCCCATCGATGTC GACACCAGTCTCATTACAGCCACGGTCTCTCCTAG CAACGGTTACTCTAGGTCNN 87 Astn2 ENSMUSG00000028373 CCCCCCGCGGCNGGGNAAACCTCNGNGCAGAAGN TCNCCTCGACCNAGGAAAACTTACTGGAGAGCTGC AGAGGAGGAAGGCAGCCTTGGAGGGCGTCCCCAG GGATC 44 Asxl1:Putative Polycomb group protein ASXL1 (Additional sex combs-like protein 1) HISTONE ACETYLTRANSFERASE 178 PT Asz1:Germ cell-specific ankyrin, SAM and basic leucine zipper domain containing protein ENSMUSG00000042548 GGTCCTTGTTCTTTACTACTAGCATGACACTCAGTC TNTATGATCTAGNAAGCAACTTAGGCTGCTCTGTAA CATCTCGGCCACTGGAGTTTGGGAGGACAGAGGG GGCAAAGCCTGACACGGCTGGTCTCCAGTGGGAG CAATAGGGGGTTGAGAGGCATCTTCCAGCCCACTT GTAAGCACACCNTGGGACCCTCTTCAACAGGCAGT TCTCTTCCTTTCTGAGAGAAGCCTGAGTCTTCTCTT CTGGCTCTGGGCATGGTAGCCTTCAGCTGGAGTGT GC ENSMUSG00000010796 ATACCAGGAAANGAGCTTTACNNNGTTGTCTTTGA GAGCAATGCCAGCCCCAGCATCAAATGTGGAAGAG TGGGAGTTGCTGTTGAAGACACGAGAGACAACCTG GTCCTCAGTGTAGA 191 PT Atf2 ENSMUSG00000027104 GGCCGCCCTCTCGCCTGTCACGNNGAACGCACGTT CGTGTGGAACCTGGCGCTAACCCATTCGTAGACGA CCTGCTTCTGGGTCGGGGTTTCGTACGTAGCAGAG CAGCTCCCTCGCTGTGATC 130 PT Atf7ip2 (Q8BPC5) activating transcription factor 7 interacting protein 2 ENSMUSG00000039200 CACNCCAATNANANAACCAGAATGAGCTGAAGNTT ACCTTTTTATAAGTATTATTAATNATACTCTTTTGAT C

89 Atp1a1Sodium/potassiumtransporting ATPase alpha-1 chain precursor 8 Atp2a2 Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (EC 3.6.3.8) (Calcium pump 2) 131 PT Atp2b1 Q8K314:PLASMA MEMBRANE CALCIUM TRANSPORTING ATPASE EC_3.6.3.8 PLASMA MEMBRANE CALCIUM PUMP PLASMA MEMBRANE CALCIUM ATPASE. 174,3 PT Atp2b1: Q8K314 :PLASMA MEMBRANE CALCIUM TRANSPORTING ATPASE EC_3.6.3.8 PLASMA MEMBRANE Atp2b1 Atp2b1: CALCIUM PUMP PLASMA MEMBRANE CALCIUM ATPASE 36 Atp2b2:Plasma membrane calcium pump isoform 2 19 Auts2:autism susceptibility candidate 2 74 AW049604 ( NM_134096) member of the TAFA family 84 B230104P22Rik : Q8cGE1 kinase ENSMUSG00000033161 CATTGTGNNCGCACATCCANTAAGCTCAGGGACCC ATATTCTGAGTGGCCACTGAAGCTGACTTGCCAGT TCTGAGAATGATGACAGGTGAAGTGTAGGCAGCGT CCAGGTGGCACTGAAGCATCCTTGTCAGGGCCTCA TTGCCTGAGTCTCTGTTGCCCACGGTCTCTCCTAG CAACGGTTACTCTA ENSMUSG00000029467 GGGCTGCCTGTGTACATTTCCATTATTGTATTGATG TTGAACCAGGGCAGTGGCTAAAGTCACTCCACTGA CCCAATTAAACAAATAAGAGCTTGTGGTTGCCCGCT TGATTGATCTGCGCAGGATAAGCAGTAAAGTTTCCT TTTCCTGGTTCGAGAGACTCCTCCTATTGCATAACT TGTGAACTGTGATTTGAGTGATACAGANAAGGAAA ATANAGATGTTCTACAAAATGTTCCTGAGATCCCAT CGAT ENSMUSG00000019943 TTGCNAAATGAATAAGNAATGNNATATGGTTNCTCT GGCTGGGAATACCAGTCATATGCAATGGNAAAAAG GAATCCCATTGTTTGGAAATAGGCTCTCATGTGATC ENSMUSG00000019943 CATACTTTACCTATCATCCTTTTNCTTCTTTACTCTG TGCTTTACCAGTACATAGCTTAATTTACACAGAATTT CTACAATTGAAGATTGGGATC ENSMUSG00000031075 GGCAGGAGAGNCCTCTAAGGTAGGTGGAGAGCTA TAGAAGACACCCATATTGACCTTTGCCCTCTTTAGG TC ENSMUSG00000029673 GCCTGCTCCACGGGTTGGGGTCTCGGTTGCAGAG AAATCCTTGTTCTCCAGTTCCTCGGCAGCAGGCTG AACCGCTGGGGTTTCTTCCAGTCCCCAGGGCAGAT GCATGATTCCTAATCCCTAATACCATGGGAAAGGG TCTCTCCTAGCAACGGTTACTCTA ENSMUSG00000054863 CCCCTTTTTTCTTTTTTCCATCNNATGTCGANAGCA GATCTCATTCAGCCACGGTTCTCTCCTAGCAACGG TTACTCTACGCCGCACAAGAGTAGAGTCACCATCG ATGTCTTTGTCTGATGGGCTCATCCGGTCTCTCCTA GCAACGGTTACTCA ENSMUSG00000020032 GGCCAGGGGTAGGGCACATTTAANTTCACTAAGCA GNAATTACAGTGTGGCAGCCGTACGGTTGTTAGGC TCCCTGCTTTTGTCCCTTGCCAACTTGTTTGCGAAC AGAGAGAGATCCCATCGATGTCGACACCAGTCTCA TTCAGCCACGGTCTCTCCTAGCAACGGTTACTCTA 181 PT B3gnt5 :UDP-GlcNAc:betaGal beta-1,3-nacetylglucosaminyltransferase 5 ENSMUSG00000022686 GAGCTCCAGTCTTCANGCTCNNNNGTTGTATNGNC AGCCATTATTGTAAAGCACAGATCATATCTTGTGAG GAACTATCACAAACCCACTNTCAAAGCATATTCATC CTACCACCCATGTTCCTCCAGGGCACACTGTAGAG TGTGTTGCTGGGGATGATTCTAGAGAGACTACAAG GCATAATTTTTCAACTGGGCTTGGAATACCTGTCAC TGGATC

94 B930037P14Rik (Q80ZJ7) sorting nexin 6 family member ENSMUSG00000056185 CCTAGCATGTTTCTCAACCAAAGAAATAGATAAAGA AAATGTCATCCATTTACACAATGTAGTGTTACTCAG CTGTTAAAGACAGTGACATCATGAAATTTGCAGACA AATGGATGGAACTAGAAAAAAATTGTCTTGAGTGAG GTGACTCAGACCCAGAAAGACAAACATGGTATGTC CTCACCTATAAGTGGACATTAGCTGTTAGTAAAGGG TGATCATGCTACAATCCATAGACCAAGAGAGACTAA AGTAACAAGGAAGGTTCAGGGTGGGGGGACTCAT GATC 112 Bace2: beta-site APP-cleaving enzyme 2 ENSMUSG00000040605 CTGTGATCATGATGGTGTATTGTTTGACNAACTACG TCCCTCCAGANCATTAGTGTGNGATC 78 Barx2 ENSMUSG00000032033 TTACCCCCAGCAGAAAAACTTCGTTCTTGAAGGTAA TTAACACATCGACCCATAACTTAACTGCATGCAGTA GAGCGAGAGACTTACGTGACTTTATCAGATGCTTC CTCTCAAGACTCAAGGATC 125 PT BC003251 (NM_024480:SH3 DOMAIN BINDING 5) 62 BC003885 (NM_198609:RIBOSOME BIOGENESIS RLP24) (but further downstream: synovial sarcoma translocation gene) ENSMUSG00000013646 GATTCAGTTTCATCCTANAAGGTTGTCNNCACATGG TTAGAACCGTGTCGACATAGTCTTCATGGAGAGCT GGGTTCCCATACTACCTGGATCTCTTTGTTTCTCCC AGCTTGAAATTCCTGGGATGATC ENSMUSG00000053740 GCTAGACATGGAAACATTTCTGTGTGAT 20 BC014699 (NM_145570) ENSMUSG00000035104 CCCCTCCTGGNTTCTCAGTCTCCGNCACTAGCGAN NGAACCCCAAGNACCACCTCCCTTCTTTGGATCTCT CCTAGCCAACGGTTACTCTANNN 115 BC030440; NM_173732 ENSMUSG00000040195 AATTATAGGTTTCATGGATC 107 Beta-parvin:Calponin-like actin- ENSMUSG00000022438 GGAGGAACAGGTACAGACTA binding in 1 32 Bin1: Myc box dependent ENSMUSG00000024381 CTTGTTGGTACTGATGATC interacting protein 1 (Bridging integrator 1) 45 Birc1c (glycine receptor, beta ENSMUSG00000066920 GCCGTTCTGTTGATGNNATACNNAATAAGCGATATC subunit ) AAACAAGATTGATC 41 Birc4:baculoviral IAP repeatcontaining ENSMUSG00000025860 GGCTGCTCTTCCAGAGGACCTGAGTTCAGGTCCCA 4 GCACCCACATGGCGAGCTCATAGCTGTCTGTAACT CCAGATTCCAGTGGATC 131 PT Bmp4:Bone morphogenetic ENSMUSG00000021835 GCTGTGCATACTCTCTGATC protein 4 precursor (BMP-4) 182 PT Bre:BRAIN AND REPRODUCTIVE ORGAN EXPRESSED 91 C030018G13Rik (MUS MUSCULUS 10 DAYS NEONATE CORTEX CDNA PRODUCT:WEAKLY) 26 C1d:nuclear DNA-binding protein; C1D protein; small unique nuclear co-repressor 162 PT C8b:complement component 8, beta subunit in intron withlow density lipoproteinreceptor,thrombospondin,eg F-like domain domains ENSMUSG00000052139 TTGGTATGCAATTGANANAACATNCNNTACATTTGC TTAATTGTATTTCTGTGTTTTTGTTNGNTTGNCTTGN TTTTTTAAAGATAAAGTCCTGTTANATGTCACAGNAT GGCCCATNCACTGTCTTCCTGCNTNANCCATCTGA ATGCTGGAAGTTTAGGCNTGTGCCACAATGCCTGT CCCTGAGTTTCTGTTGTTCAAAATGTATGATC ENSMUSG00000047839 CAGATACTACATCTTGGTGTCNGACTTAGCAAACAT TGGGTAACTGTGGTAGCAGTGATGTGCTATGACTT GGTACTGAAATCTAGTCATGTGGTCTA ENSMUSG00000000581 CAGAATCNNAGATTCAGATTATGAACGTATACGTTC TGGCATATGTGTGTTCATACATACATACATATGCAT GAATATATCATATGTATGTGAATTTATTG ENSMUSG00000029656 TCNGCGCTTNNATCTTAACTNNNCGTATCATTGATT GGACTTAAGGTAGATGCNCTGATTCAGAAATGCAA ATGTNNGGGTCTGTGTTTGCAAGGCCTTACANTGG NAAATGATGNANTTCNCACT

128 PT Cabc1:Chaperone-activity of bc1 complex-like, mitochondrial precursor (Chaperone-ABC1-like) 113 CacN1e (calcium channel, voltage-dependent, R type, alpha 1E subunit ) 17 Cacna2d1:Dihydropyridinesensitive L-type, calcium channel alpha-2/delta subunits precursor 57 Camk1:Calcium/calmodulindependent protein kinase type I 95 Cancab4 CALCIUM CHANNEL, VOLTAGE- DEPENDENT, BETA 4 SUBUNIT ENSMUSG00000026489 CTCTCTCTCCTCTGTGTTCCCCANNCCTCCCCATGG GTGGGAGGATGTTCAGGCTGCAGGACCACTTTAAA AAAAAGTCAGGGGAGAGCCAGGCTGTGGTAGCATA TGCCTTTTAATCCCAGCATTTAGGAAGCAGAGGCA GGATGATC ENSMUSG00000004110 ACACCTCTTCATGGATTGAGANGCGTCGNNNGCGG TGTCCNNNAANCTTTGGANAGAGCGACGACTATTC TCGTAGATGGCCGCAAGCTTCCTCTCCTCCGCTCA TGTGAACCATGNAAGTCCCGAGGACCACCAACCCC TTGACACACATACACGTTTGATCCCATCGATGTCGA CACCAGTCTCATTCAGCCACGGTCTCTCCTANCAA CGGTTACTCTA ENSMUSG00000040118 CCAGGCAAATTCACCACATTCTACTG ENSMUSG00000039145 GGACCCTNATGNTGCAGGATGTGACACCACAGATG AAGCTCTGACCACATGTCAGTCTGAATACTGNGTAA ATTNTTCCCTCCCATCGTCCTGTAGGCCAGNCAAA GTCTTGNYYACANCTAGTACGAGNATATGTCTGTTC CATANGCAATATATGATGTCAAGGGATAGGCACCA AAAGCTGAATTTCCTCGTGTACCACTTTCGTCGGCC CAGTGMGCCCATACACAYAATGAGTAAGTGCACAC AGCCAGCGATCAGCGA ENSMUSG00000017412 CGGGGAGGACCCTTCCTTCCTTCAGCTATGGNTAG CTTG 64 Catnb b-catenin ENSMUSG00000006932 GGACATTAGTGGGATGAGCAGCGNCAACTGCGTG GATGTGATC 97 Ccbe1 (collagen and calcium binding EGF domains 1) 235 PT Ccne1, G1/S-SPECIFIC CYCLIN E1 44 Ccne2, G1/S-SPECIFIC CYCLIN E2 50 Cd226:CD226 antigen precursor (Platelet and T cell activation antigen 1) 140 PT Cdh1:Epithelial-cadherin precursor (E-cadherin) (Uvomorulin) (Cadherin-1) (ARC-1) ENSMUSG00000046318 GCCTAAGGCTTTCACTATGTGGGACNTCTTTGGAA CTGAAAATTTGCTGCAGNTAGACTAGGCTCAGGCT GGCCTTGAATCCCATCGATGTCGACACCAGTCTCA TTCAGCCACGGTCTCTCCTAGCAACGGTTACTCTAN GGNNTCTCCTAGNANCGGTTACTCTA ENSMUSG00000026826 TCAAGATGCCCATAGATGCTGTGTCCAGAGAGGTA CACTTTCTGGTCCATGGATC ENSMUSG00000028212 ATCCCAATGCAGATACCAGGGCTCCTCCCTGACAC TTCAGTCAGGGTTAATTTCTTTCCTGTTCCCCACGA GCAGGAGGCATGACTACTGGTTTTATTAAAATCCCC ATTAAAGGCAAT ENSMUSG00000034028 TAGAGGATGCTTGGAGGCCTTGTGTGATC ENSMUSG00000000303 GTGTGTGTGTGTTGTGTTTGCTTATGTGAGAGCAG GCACCTGTTGAGGCCAGAAGAGGATGTCTGATC 90 Cdh11 ENSMUSG00000031673 TTCATGAAATGCCCNTATGAGTCTAAAACGACATTA TCTTTATAGCACAGNAAGCT::::GACACAAGCATCTA GTTATATGATCACTGGNTGTCCAATCCCTAAGCTTC ACAGTGATGTGTACCTATGCATGTGAT 11 Cdh2:Neural-cadherin precursor (N-cadherin) (Cadherin-2) ENSMUSG00000024304 GGAAAATAAAAGTTATATGAGGNAAGTTGGAGAAG GGGATTTGGAGGGAGAGGGGAATGGGAGGCTNNA TGATC 74 Cdh6 ENSMUSG00000039385 AGCTGTAGTACTCCTTCNGTTCTNCCTTGGGTAGG NGAAAAGCATNGANGTCNCGAGTAGNGGNTAAGG AGGGAGCNNCCTANGAGGGCATAAGTANACAGGG GCAGGGAGGANGGAAAGATAGAGTGGAACCTGAT C 11 Cdk6 CYCLIN-DEPENDENT KINASE 6 ENSMUSG00000040274 GCTCTGATTAATAAATCCCTTGGAAGTTCTGAATAT GCTGTGCAGCCAGCGTGTCTGATC

44 Centg2:centaurin, gamma 2 ENSMUSG00000055013 CNATNTTTCCTTTGGGACAAAGGCTTGAAAGTGGG TTTGCAATAGTNAAGGTGTTAGGNGTGTTGGAAGT CTNGCCCNCTAGGGGTGCAAGGNCNTTACT 89 Centg2:centaurin, gamma 2 ENSMUSG00000055013 CGTGAAGGCGGAGCGNCGTGTTCTCAGCGGGGCT GAAATATTCCACGCGTTTTTGATC 6 Chmp2b (CHROMATIN MODIFYING 2B CHMP2B) 189 PT Ckap1 cytoskeletonassociated protein 1 16 Cmkor1:(Chemokine orphan receptor 1)G PROTEIN- COUPLED RECEPTOR RDC1 HOMOLOG ENSMUSG00000004843 TCCCCCTTGTTTCTTTTTTAAACCAAGCACGCTGGA GATCTTATTTGCATTTTGCNNTNTCTTTGATTGTNG GGCCCTTGTTCACTATGGAATCTTCTGCACCTGANA TTCTCTCTTCCATCTCATTGTATTTTGTTGCTGATGC TCGTATCTATGGGTCCAGATTTCTTTCCCACGGTCT CTACTAGCAACGGTT ENSMUSG00000006095 GTGGGTAGCTGACACCCTGTCTGGCAAGTTAAGAC ATGAACGTTAGGCAAGGCAAGTCCCCTACCACAGT TGAATAACACCCCAACCAATGGGAGCAGGGTAAGT ATACAACAAAGACGTGTCCCTAAGGAAGCCCCTAT TCCTAATCCCGATTAACTTGTTTGTGGATTTTAGAC TTAAAAGCCTTGTATGATC ENSMUSG00000044337 CCTCTGCCAAGCAGGGATGGAAAGACAGGTGATC 140 PT Cnga3:Cyclic-nucleotide-gated cation channel alpha 3 (CNG channel alpha 3) (CNG-3) (CNG3) (Cyclic nucleotide gated channel alpha 3) (Cone photoreceptor cgmp-gated channel alpha subunit). ENSMUSG00000026114 GACCCNGGCAAGAGGAAGCAGNNCTCNTAAGAAG CTGAGNCATCNCTCCAGCCCCCCCCCCATTAGGGC GAANTGAACATGTAACCCCTTAAAGGC 31 Cntn6; contactin 6 ENSMUSG00000030092 TTACCATCATATGGTATGATACAAGAAGGCACAGAT GTCCTGAAAGCACTTAGGTGCACTCTGAATTGCTG TATACAAAAGATAACAGAGGAGCTGAGCTAAACCTT AAGGCATGTGTAGTGGCTGCTTTAACAGCTATTGG AGAGTTTCCCCTGCGGATGAGCCCATCAGACAAAG CA 72 Cntnap2:contactin associated ENSMUSG00000057136 AAATGTCTACATTGGTCCAAAATCAGAAGGGATC protein-like 2 83 Cntnap2:contactin associated protein-like 2 ENSMUSG00000057136 CTATCCTGGAAATTACCATAATGCACCATGATC 100 COP COATED VESICLE MEMBRANE P24 PRECURSOR (predicted gene) ENSMUSG00000057844 GGGGATTNTGAAAGCCCTTGCGTCCAAAGNATAGN GTTCTTTTTGGGCAATGTCTTACATCTATTTTCACCC GAGCCCTNGAATTAGAAAATTGATTCCTCTTTTGCA GCCCTATTACCATGTCAGGGATTTCTACTGTCCATT TGACGATGTGCAGCCGCAATAACAAAACCCGGTGA TTACTGGANC ENSMUSG00000030127 CCCATCTCTGGAATTTCTGATC 51 Cops7a: Proteasome component region PCI 163 PT Coro2b ENSMUSG00000041729 CTGGGGATCCTTGAAGGTGCNNTAGGGTGAGAATT ATAATATTGGGGTGGGGTGCTCTCTTGTGGTAATTA TGAAATATTTTTGATTGTGTGCATGGTGTCTGTGTG TTTAGGTTGGAGGTCAGAGTTCAACCTCTGGACTT CCTTAGAGGCCATCCATCTTATTTTTAGACACAGGC TCTCTCACTGTACATNGGACTTACCAGCTGATC 78 Coro6;coronin G-protein beta WD-40 repeat 190 PT Cox7c HIGH MOBILITY GROUP HMG 22 Cox7c:Cytochrome c oxidase polypeptide VIIc ENSMUSG00000020836 GAGGCCCCCTTGTCGGTAAGCTCTGAGATC ENSMUSG00000017778 GATGTACCTCAGTGTGACACAACAGTTTAGGTGGN AGAGATGGAATACCTGAGTGGCACATGCGAGGTAG AGAGAAGAAATAGTGGTGACCTGTCTTTGCTGATC ENSMUSG00000017778 CCAGTCTCATTCAGCCATGATC

21 Cpne5: Copine V ENSMUSG00000024008 ATCTTTGTCCAATCATTTAGANTTGATGATTTTAAAA CACATCCCTGCTGGGCGTGGTGNCACATGCCTTTA ATCTCAGCACTTGGGAGACAGTGGCAGGTGGATTT CTGAGTTCGAGGCCAGCCTGATC 11 Crisp2; cofactor required for Sp1 transcriptional activation subunit 2 ENSMUSG00000064127 CTTAAGAGGAGGAGTGTGGTGATGGGAGCTCCCA GGGTGACAGTGGATGAGACTCACAGCCCACCAGG GTGCAAGCCCTGCAGGCAGGTCCAGTGATAGGAA AGCTGGATGCTGAAGACTAACGGATGAGCCCATCA GACAAGNNACTTNTNGANGTTCCANCCAAGCAT 91 Cry1:CRYPTOCHROME ENSMUSG00000020038 GAGTTGCTCNTTGGATNGCANGTCTGACGTNGCGT CGTGTNCGTTGTCTCTCTTTGCTAGACACACTGCG GGAGGGTGNTCTTTCTGATC 111 Crygf: crystallin, gamma F ENSMUSG00000025945 CACGGNTCTCTCCTAGCAACGGTTTACTCTAAGGG ATCTTTGTCTGATGGGCTCATCCGTTTGTGTCTTTG TCTGATGCGGCTCATCCGNTTTGTGTCTTTGCCNG AAGCGGCATCANCCNATTGTGTCTCTCCTAGCAAC GGTTACTC 89 Csnk2a1: Casein kinase II, alpha chain (CK II) ENSMUSG00000057808 CTTTAATAGTAGAGTATACATAGCATCTGNAACAGG ANNTTTCTGCTGGAAGCANGNAATTTTCACGGGGC GTACTGCTCCCCTTNGTTTAGTGCAAGAGTAAGGC AGCCAACCTCCCAGTGTCCTGCTTGTCCAGTCTAG ACAGCGTGCTGTCGGCAGTCAAGGTAAAGGGCCT GTGGCCACGGTCTCTCCTAGCAACGGTTACTCTA 48 Ctsb:CATHEPSIN B CYSTEINE PROTEINASE PRECURSOR ENSMUSG00000021939 CGGTANGCAGAGGCAGATTTATCTCTGCAGTTTGT GNNCCCCATCATGCCCCGGCCATCCTGATC 134 D0H4S114 ENSMUSG00000042834 AATCACCAGGCGTCGTCAACCGCACAGACCATATA TGTCCGCTAGGATC 97 PT D12Ertd771e ENSMUSG00000056770 AGTNCGTCGGCAGCCGGAAGCAGAAGAGTATGAA CAGTTGGTGCCCACTTCACTTTCTCCACTTTCCTGT TCATTCAGCTCGAGTCCACCGGATGGGATGGNTCC GACTACTCAAGGTGAATCTTCTCTCCTCAGTTAGAN CTGCCTGGTCCNCACAGACGCACCCGGANGTGTG TTTCCATGNCGACACCGAATCAGATC 116 D130059P03Rik ENSMUSG00000038538 CCTTCCGGNGTTTTACGGGCTNTCCCACCCTGCAA AGAAAGNAGCATACGTTAGACTTATTCAGTACCTGT ACTGTTTCCATAAATATATAACAAAAAGACCTGTTA GAAAAATTCACACAATTTTTACAGAGAAACCCTCTG TAGACAACTGGATCCCATCGATGTCGACACCAGTC TCATTCAGCCACGGTCTCTCCTAGCAACGGTTACTC TAA 116 PT D3Bwg0562e:plasticity related gene 1:LIPID PHOSPHATE PHOSPHOHYDROLASE EC_3.1.3.4 PHOSPHATIDIC ACID PHOSPHATASE PHOSPHATIDATE PHOSPHOHYDROLASE TYPE PAP PAP2 ENSMUSG00000044667 CCCCTTTCTTTGCAGCATGTTGTNNCACACTTCTGT CTCTTTGTGTGATAATCTCTTCCCCTTGAATGTGAT TTATACCTTGTACCTTACCACACCATTTCTAGAAAC ACTTCCTGATGTTCCATTGGCAATTCCCTATTCCTT AGAACTACATTCTGTCACTAGGCATGTTGTAACCAT TTACACTAATGCTTGTATACTATGAGTCTCTGAGGG ATGATC 68 D530031C13Rik (NM_177269) 61 D730001G18Rik (HYPOTHETICAL PROKARYOTIC MEMBRANE LIPOPROTEIN LIPID ATTACHMENT SITE CONTAINING PROTEIN) 28 D8Ertd594e:similar to BH3- only member B protein kinase ENSMUSG00000052812 GATTCATTTTGGCTCATGATC ENSMUSG00000045006 CACTTGGGAGACGAGACTCCAGCCATATCCATGAA GGATTATCCTGATTGTATTATTTGAGGTGAGAAGAC CCACCATGGTTGTGATC ENSMUSG00000031563 CAATAGCAACTGAAGAGATANGCTGAAACCTGCCT TTACTTCTGAAAGGAGAGTCGGGAGAAACTGATC

76 Dach1:Dachshund homolog 1 (Dach1) 31 Dbi:Acyl-CoA-binding protein (ACBP) 46 Ddx3,DEAD-BOX PROTEIN 3 (DEAD-BOX RNA HELICASE DEAD3) (MDEAD3) 14 Defb7 (defensin related beta 7) 171 PT Dhx40 (ATP DEPENDENT RNA HELICASE) 10 Dicer1:Endoribonuclease Dicer Double-strand-specific ribonuclease mdcr-1 78 Dlg5 SIMILAR TO DISCS, LARGE HOMOLOG 5 (DROSOPHILA 132 Dlgap2: SAP90/PSD-95 associated protein 2; PSD- 95/SAP90-binding protein 2; SAP90/PSD-95-associated protein 2 60 Dmrt3:Doublesex- and mab-3- related transcription factor 1 116 Dmrta1(doublesex and mab-3 related transcription factor like family A1; doublesex and mab- 3 related transcription factor 4.) 136 Dnahc5: dynein, axonemal, heavy chain 5; dynein, axon, heavy chain 5; axonemal dynein heavy chain 5 31 Dnahc5:DYNEIN HEAVY CHAIN, CYTOSOLIC DYHC CYTOPLASMIC DYNEIN HEAVY 81 Dnaja1: DnaJ homolog subfamily A member 1 (Heat shock 40 kda protein 4) (DnaJ protein homolog 2) (HSJ-2). 191,2 PT Dnm2:Dynamin 2 INTERFERON INDUCED GTP BINDING MX 76 Dok5:Docking protein 5 (Downstream of tyrosine kinase 5) ENSMUSG00000055639 TCATTATATTTTACTTAGGTGTAAAAAGAACATCAGA CTGCCTGTTTCTGTGATC ENSMUSG00000026385 TTCATTTTCATGACCATCTCTACTGTGCTTCCCCAC ACCTGATC ENSMUSG00000000787 CTTTGAGGACTTGGCGTGGTGCTGTGTTTTGAGGA GATGGCCTTGGGCCCA ENSMUSG00000037790 CTTACACAGCAGAGGGAAGTAGAAAACCGGCCTGA CCAGGGGCACAAATCCCTTCTGGTCAGTGCCAGCA CCCAGTCACCTAGGGCGTGGAGTCTGTGGACAGC CCCACAGTCCCCAGAGGACTCTCCACGTGATC ENSMUSG00000018425 TTCCCGCTGTTCCNGATGACTGTTAGNTAGGAGCG CGCTGGGNTGTTCCTGTGTATGTCTGTCNCTAGTTA CCATC ENSMUSG00000041415 GATGCCGTNTCTTGCTCTGACGGAGTTGTGATC ENSMUSG00000038942 ATTAGTGAATNCANGTCACGGTTGAANGAACTCCC CCNCATTNCTTGAAGACNGCGTGCTNAAGTGCGGT NTATGNTGCAGGACACAGTAGAATCGNAACCTCAT ANTAATCAAGGGCCCTGGAAATACCACCAAATGAT GCAAAGATACAAAAGTAATTTGAAAGGACAGTTCTC ATGGCTA ENSMUSG00000047495 GNNNCGGCGCGGCCACACACAATCTCACAGCGTC TCCCCGGTCCAAGNATCCCATCGATGGTCGACACC AGTCTCATTCAGCCACGGTCTCTCCTAGGCAACGG TTACTCAAAA ENSMUSG00000042372 CGTGTGTATCATGACAGAGGACCTGCAGGTAGATG ATCC ENSMUSG00000043753 GTAGTAGGGAAAGCTGNTAGCNTGCTAGTTNNCCT GGTTGTCAACTTGCACTATATCTGCAATGCAACTAC AATCCAGGNATTGGGAAGGCTCACCAGTGATCCTA ATCTGGAGACTGGGAGATAGAAATTTCTGATATGG ATCCCATCGATGTCGACACCAGTCTCATTCAGCCA CGGTCTCTCCNAGCAACGGTTACTCNAA ENSMUSG00000022262 CTTCCCTAACCTTTCACAATCTNTNCAGATAGGTTN TNTCCTCACTCCCTTCTTGTCCTCATCTTTCTGCTTA CCACTATCAGGTTGATCTTTACAAAATGCAATGAGA TC ENSMUSG00000022262 GGCCTTTCTGGGGTAATGTGAATGACCATTTTAACT TTGTTTAGAGTGATGATC ENSMUSG00000028410 AACCAGCANGGCGCTCAGGCGCACTACACCCCNN AAACATGAGAACATGGCCCACNGAATCAACTGATG GGGACTCATGGGAATTTGAGAGGTCAGGAAATCTA TAGGAGCTCTGACCTAGCGTC ENSMUSG00000040265 ATAGGTCACTAGTGCCATCAAGGGNCACAAATATAT CTAGACTTAATGATC ENSMUSG00000027560 CTTTTGGCTTCCCTTCTTTCTCNNTCTCTCCTCNNC CTCCAATCCTCTCTTTCCCTTCTCTCTCCTCTTCTGA TCCCACCCCTCTTACGGAACACATTTATTTAATCAA AATGTTGATTTACAAAAAAATGATC

28 Dpyd: DIHYDROPYRIMIDINE DEHYDROGENASE [NADP+] 182,2 PT Dusp6:Dual specificity protein phosphatase 6 (Mitogenactivated protein kinase phosphatase 3) (MAP kinase phosphatase 3) (MKP-3) ENSMUSG00000033308 GGAAAACAATAACTATNGAANAACTAGAANCATATA TTTGGNAGACTCAGCTATGATGNGAATAATCACAGT ACAAACTCTGG ENSMUSG00000019960 CCTTAGTTTCCATGNACNCCGCCGTGGNAAAAATT GAATGCAGGNATGGNTTTGACTTTCACTGGATACC CATCACATGCCCTAGCGTCTTAACAAGCAGTCTTTG CTTATGTTATTTCATTCACGCTTGTAGGACTCCCCG TGGATGTCATCTGAAATCCAGGGAGGTTTTTNAAAG TGCCCGGNATCACANANCTAGNGAATTGGTGAGTT TAAACTGGATCCCACNCCTACCGGATTTCAAAACAT GATC 28 E030011O05Rik ENSMUSG00000048790 ACCAAAGGTNACTGAAGAAACAAGCANATAAGACC AAGANCCCAAACTTNANATNACTTGCATTGAATGAN GAACAAAAGAAATAAAACAAACATAATNCATGANGA TANCAAAAGATTGAAAAGNCAACCAAGGAGGCACA AACAACG 11 E2F7 in intron but may enhance expression of small isoform 74 Edar: Tumor necrosis factor receptor superfamily member EDAR precursor (Anhidrotic ectodysplasin receptor 1) (Ectodysplasin-A receptor) 10 Edg5 ( lysophospholipid receptor B2) 161 PT Ednra:Endothelin-1 receptor precursor (ET-A) 187 PT Egfr:RECEPTOR TYROSINE KINASE ERBB PRECURSOR ENSMUSG00000020185 TANAAACATGGCTCCAGGCANGTGGAGCCANGGCA GTCAAAGCTCGNCNAANTNNNNCTCTGTTTNAAGG AGTCGCTGANTCNNTGACACCATCGANGAC ENSMUSG00000003227 TTCCCTTTCNGTCTNTTNTGATTCTCCANGCACNCC TCAAAGATCCTTAACTCGTATCGCCATNTTCCNCAN ACGGTTGGGCCATNCACTTCCNGGTATCTTTTTCCT CCGGCGTCTGATC ENSMUSG00000043895 CCCTGGAAGTAGTACAGACAGAATGCTGACACCCT TTGTATCAAGTGGCAAATGTCTAGCCCTAAGCTCCA GCCTGCGGTCACCCTAGACCCTTAATGATC ENSMUSG00000031616 CTGNTTGCTTGTCCTTTCGGNTTCCCTANGAGNTAG CGNCGACTATCACTCCACTCTAGAGTNNNCAAGGA ATCCAATGGCATCTTCTATGGTGTGATC ENSMUSG00000020122 GTATCTCTAGCCCTTTGCAGATGATAAGTATGGTTT TGATTTCATTGCTAAAATCTAGCTTGTTTGGAGATA GGGTTTGAGATTATGATC 15 Egr3 ENSMUSG00000033730 GCNNCTTCGGTTGTGGTCAGCNTTCATCTAGGGGG AAATCGCATGTATCTCGCTCANNTCCGCATGGAAA AGGAGAAGCCAAACACGTAAGCTTCACAAAGACTG GAAACCTGGCTTGGGATTTTCACCTCAGTAGGTAG AATACCCGAACGGCCCGAAGTCCTGGCCTCCATCC GCAGCACTACAAAGTAAACAGTAGCAATGTCTGTC CNCAGTCATGCTGCAGCCAAGTGGCTGAGTTGAGA TTTAGGGTCTCTCCTAGCAACGGTTACTC 10 Egr3 ENSMUSG00000033730 GGCATCTTCGGNGNGTCAGCANTACNATAGATGAC CTCACATGAACTCCTCAACAGCCNTGAAAAGACAG GCNAACACTAAGCTTCACAAAGACAAGAACCTGGC ATGGGTCTACAGCTCAGAGGTAGAATACCCGAACA GAACAAGTCCTGGACGTCCATCCACAGCACTACAA AGTAAACAGTAACAATGTCCTGTCCACAGTCATGCT GCAGCCAAGTGGCTGAGTTGAGATTTGGGTCTTGG ATGGAGGTCACAACTCCAAAGCNGGCTAAGAGTCA GAGGGGAGAGCAAATAGCTGCTGGCTTGTCACGT GACCTCCTCAGTTTGGAATTGTGATC 173 PT Eif4g2:Eukaryotic translation initiation factor 4 gamma 2 (eif-4-gamma 2) (eif-4g 2) (eif4g 2) (p97) (Novel APOBEC-1 target 1) ENSMUSG00000005610 GTGGGGTACCAGAAATTTGTGGTGCAGCTGATCCT TACAGTATTTTATAGTGATC

44 Elk3, ETS-DOMAIN PROTEIN ELK-3 92 En2:Homeobox protein engrailed-2 (Mo-En-2) 76 Epb4.1l1 BAND 4.1-LIKE PROTEIN 1 (NEURONAL PROTEIN 114 Epm2a (laforin:tyrosine specific protein phosphatase and dual specificity protein phosphatase) ENSMUSG00000008398 CGTTCCAGNAGCAAAAACCTAGTGGCACTGAGGTA AAAGTAAGCCANTAGGCCACTCAATTCTTCATGACC NTTTTATCTAAAACCACACATGAAGAAGCAACAGTA AGTGACNTAGTACAGTTAGTGGGACAGGTTTAAAAT AACTTTGNTATTCTTGGAAGATGCTGNTTTGTTTGG TTGGCCTTTTTGTTTTCTTTCAAGACAGGGNTTCTC TGTGTAACCCTGGNTTGCCCTGGCACTTGTCCTATA NACCAGGTTAGNCTATCT ENSMUSG00000039095 TCCCNNTTGTTCTTACCCTTGCTCCCTTGCTNNCCC TCTTTCCACCTTCCCTCCCCTCCTCTCTCCATATGG CCATGACCAGCCTCTGCTTCCTCACTCTCTCCCTGT ENSMUSG00000027624 GACCCTGACCTTCCCATGCCTCAGCTTCTCTGTTTA GGCGGCTAGGAAGCTCAGTGATC ENSMUSG00000055493 165 bp than GGCACTGTCTTCATCCTTTGCCGTGCCACCGNAAC CTTGTC 32 Eras: ES cell-expressed Ras; small GTPase E-Ras 88 Eras: ES cell-expressed Ras; small GTPase E-Ras ENSMUSG00000031160 CAGTTTCTGGTAAGGAAGGCCGGGACCTCTGACTT CCTCGGAAAGTAGTGGTGAGTTCCGCAGGCTCGAG TGAGGGTTACAAGCCATACGGAATTAGAAAATTGC CTTGTCCGGGTTCTGAACCACAGCGATGGCAAATA CATCCTGACCGCATTCCGCAATCCTTGCAGGTACY TTGCTAGGGCTGATC ENSMUSG00000031160 TCTTTCACCTCTTCCTTGAGCTGCTGGGGGAATGG CTTTGCCTACAAAGTCTAGCATCTTGCGTACCTGAG ACTCCGGCACCCACATGCACCAGATC ENSMUSG00000031160 TCTGTAGCAGCTGTTTGTCTGAGCGCCCTGTACTA GGGGGCCGGTGGGCTGGGTGACAATGATC 89 Eras: ES cell-expressed Ras; small GTPase E-Ras 181 PT Erbb4 ENSMUSG00000062209 GAGAAGAANGNGTCNNTTCACGGCNNCTTTCTTAG AAGAACTCTTTCATCTANCAATACAGAAATATCACC ATTACCACTCCTAAGTTATGATGATTTTAGGCACAT AACAACAAAAACCTTCTGTCAGTTGGTAATATATTC ATTAAGATAANTCATTAAGGGAACTGCTATGTATTT AGTTCTTCTAGGACTGCATCTAACCTTGCCCTGNAA AATATTGACNAATAAGCAAGTAGCCNACAAAA 67 Esrrb; Steroid hormone receptor ERR2 (Estrogenrelated receptor, beta) (ERRbeta) ENSMUSG00000021255 CATAGCCTCTGCTTCAGTTCCTGCCTCCAGGTTCCT GCCTCCACTCTCCTTGAAGATGGCCCAAAGTGAAA TAAATCCCTTCCTCTCTAAGTTGCTTTTGATCCCATC GATGTCGACACCAGTCTCATTCAGCCACGGTCTCT CCTAGCAACGGTTACTCTAA ENSMUSG00000058748 GATACAGTTATTTGCACCCAACCNNGGACAGACGC NNNATGATC 43 est NM_145591:similar to zinc finger protein 97 63 Ets2, C-ETS-2 PROTEIN ENSMUSG00000022895 CTTTTTCAAATGTTTGNTCTCTCCTCATCTATAGAAC TGATATCAACCCTAGCTCACTAGGCTGGACTCTCAC ATGTTAGGAAAAGCTTGCTTCTTGTACAGCACGNTG CCTGCCATCTCCTGCTTTGCAATGCTCACTTACAAG AGTCTGTTGTATC 7 F830005K03Rik ENSMUSG00000051859 TCTNCATTTCGTAGCATCTAATGANGCCNAGANNNN NGGAAGACGATGTGCTGACTGATTCAGTGCTTCTT ATAAGGGGGANCAGAANATCACAGGTAGAAATATG GTAGACNAATTGTGNAGCCGAGACTGNNCACAGAC TACCNTCCTNACACTGNCTCNCNTGGTAGATC 5 F930048N03Rik (XP_487601.2, Zn-finger, FYVE type gene) ENSMUSG00000061815 CCCTAATGGNAACGCCACNTNCGNCCTATCCTGGG NNNAAGCCAGGNACACTGGAATTCGCTCTCGTAGG AAATGGCATTCGCTTGAAGTGTGCACACCAGGGGA GTCACGTCCCTTCTCTGCAGTCTTGGGGGGC

74 Fabp4 (Fatty acid-binding protein) ENSMUSG00000062515 CGNNTACGTGNGGCCATCTTCCTNCATNNATNAGG CTCCNTCCTCCCAGAAGACAGGCTCCACCCTTCAT GCNGACAGGAAANACACCTCAATGNAGTCAGGCTC CACCCTCCCATACAGTTNNGCNCCANCCACANANG GTTTNCCCTAGAAAGCAATCCCNGCCTCCTCTCTG GCTATCANAGACTGGATCCCATCGATGNNTAACAN CGGNTCTCATTCAGCCACGGCCNTCTCCTCAGGAA CGGTTTACTCNA 10 Fat3 protocadherin ENSMUSG00000064286 GAAAGTCACTACTTCTGAAAAGTCGCAAGACTTGNT GAGNTATATGTGGCANACACACAGACTCTTTAACAT TYGNCAATATACGAGGAGACTCATGATC 44 Fau; Ubiquitin-like protein FUBI ENSMUSG00000050299 CCCCACTCAGAGCNACAAATGTCTCTAGACTATTTG NGTGTGTGTGTGTTATTCATGATC 12 Fbxw4 ENSMUSG00000040913 TGGGGCCACCACATCTCGCCCANTTCCGCCTCCGG NAAATCTCACTGGCCTGGGGTNCACATGATGAGGT ATAGNTGTGCTGAACTGGATGCATCCTCATCGGAT GTCGACACCAGTCTCTTTCNCCCGACGGTCTCTCC TAGCAACGGTTACTCTANN 16 Fbxw4 ENSMUSG00000040913 GGTGCCACCACTTTCTCGCCCATCTCGCCTCCTCA GCTCTCACTGGCCTGGGGCTCACTGATGAGGTTAG TGTGCTGAACTGGTGATC 29 Fbxw4 ENSMUSG00000040913 GGTGCCACCACATCTCGCCCATCCCGCCTCCTCAG CTCTCACTGGCCTGGGGCTCACTGTATGAGGTTAG TGTGCTGAACTGGGGATC 45 Fbxw4 ENSMUSG00000029780 ACCGGTATCTGGTATTGCCCTAGAAATTACTTTTTG ATCTTAACAAAACAACAACAAAAACCCCGCCTACCT TGGCCCTTTAGTGTTCTGGGTCTGTAGAGGAGATC AATGCATGCTTTACCTTTGGAAGGGTAAATGACATG AT 51 Fbxw4 ENSMUSG00000040913 GATTTTGNCTTCTCNAGNACATGGGTTTGGTTAGCN TTGNATGGCACTGTCTTTCTGATC 58 Fbxw4 ENSMUSG00000040913 TTTAGTATACGTATTCGNATATACGTTTATACCTGG GCTTTATACAAATTTATCAGGCAAAAAGCAATCACA AGTAGAAACAACTTAAGAAGCCCACTTACCTATAGT GCTAGTCCCAGTAGTAACAGTCTATCTCTGTCCTTG ACAATGTTTGCTTCTCTTCAAGAGACTAGTCACATT TACCACTAGCACCCTACCAGGCTGGAAAAGTAAAC CAGGCTGGCCTTGAACTCAGAGATC 62 Fbxw4 ENSMUSG00000040913 CCGCCTCNNTCGCACACGGTCTGCTCCNAGAANGA GGNCTCTNTGTGCTGAACTGGGGATC 80 Fbxw4 ENSMUSG00000040913 AGAATCCATATAAAATTCCGTCTTCTATCAGNATCA ACAGAGCTCAGCAAGATGGATATTAATGCGATAGC TTTGGGCTCTCTCCTAGCAACGGGTTACTCTA 111 Fbxw4 ENSMUSG00000040913 ACAGGNAACACTGAGTCTGCANCGTTCTAGCAGGA ACCTCAGGGTTCAGTCATCCCAGCATCTCGTCACT GAGCCAACTGAACAACCATCTGTAACTCTAGTTACG GGGGGTCCCACGGATACTCTCTCTAGCAACGGTTA CTCTA 108 PT Fbxw4 ENSMUSG00000040913 AGAAATGTGNAAATGTAAATGGNATNCCTAAAGCAA GCCGAAGAACATCTTNAAGTGNAATCTGCCTGAAA CGGCCCGAGGGACCACNTCTCTGCAAAANGACAC CTCAATATGACCCTTCCNGAACATNGTCTGCTCCTG AGCCGGNCATAGACCCAATGGNCGCTTGTTGTAC 130 PT Fbxw4 ENSMUSG00000040913 CTGTAAGGAGCAACAGAAAGCCNAACTTTGCTTTG GTTGGCTTGAATCCCAGGCATTTTAGCCAACTTCAA TTATAGTTCAATATTCCTTCAATGAGTTACTCTGTCC AAGCACATGATC 17 Fbxw4 ENSMUSG00000040913 GCGATGTATCTGCTGCTACTCTGCATCTATTTTTAT TTACAACCACAGGGCAGACGGCAGAGACCGGAAC CTGATC 53 Fbxw4 ENSMUSG00000040913 CGTTTAGATATCTGAACCAAATGACTGAAATCTTTTT TGTGACACTTCCCCCAGCAATTGATC

35 Fem1c:SEX DETERMINING ENSMUSG00000033319 ACCAGCATGTCCTTTCACTTGTTGTATTGATC FEM 1 63 Fgf10 ENSMUSG00000021732 CCAGTAGCCACCACCTCCAGCTGTCTCTTTGCCTC GCACCAGGTCTTACCCTTCCAGTATGTTCCTTCTGA TGAGACAATTTCCAGTGCCGAGAGTTTCAGTACAAT GTGGAAATGGATACTGACACATTGTGCCTCAGCCT TTCCCCACCTGCCGGGCTGCTGTTGCTGCTTCTTG TTGCTCTTTTTGGTGTCTTCGTTCCCTGGGTCTCTC CTA 137 PT Fgf10 ENSMUSG00000021732 CCTTTCTAGGTCCTGAGACAATTCNNAGATTCCCAT CCCTAATGTCAATAAAATAAAATAAACCAAAGGTTC ACCCATGTATATATGTATGCATACTCTTTATGAGTTA AATTTTCATATCTTCTTTGTTAGATC 150 PT Fgf10 ENSMUSG00000021732 GAGGNGAAGGCNNNNNANAGCGNNNAAGNCAGGC GCCCCCCAAANNCAGAAGTGGCGNGTTCGGANAG ACTTCACGATCGAACAGGCACCACCANACNGAG 44 Fgf10 ENSMUSG00000021732 GAGNATTTCCAGTGCCGAGAGTTTCAGNACAATGT AGGAAATGGATACTGACACATTGTGCCTCAGCCTTT CCCCACCTGCCGGGCTGCTGTTGCTGCTTCTTGTT GCTCTTTTTGGTGTCTTCGTTCCCTGTCACCTGCCA AGCTC 79 Fgf15 ENSMUSG00000031073 AGGTNCTGGTAGATCAGAATTTCCTGGGCACGCCC ACCTCACACCCTGCAATTCGTTCCCACATTGCTGTA ATTATAAAAAGCCACTTAATAGACTCTCGCTCTCCG TGTGAAAAGCACAGGCTCTTCTATACACAGAGAGA TC 51 Fgf17 ENSMUSG00000022101 CCGGGCCAGGTGGGGCTGCGAAGTCGGAGCTGGT CCGATTGGCGTACTCGCTCTCTTGGGCTACTGGCT TCGGGWCAGAGGTCCCCGGGCGCAAAGGATTGGA GCTGCGAGAGCGTCCTCTATCAGGAGGCTGGCCC CTATGATC 5 Fgf3 ENSMUSG00000031074 GGGAACAGAGGTACTTGTGGAAACCGCCCCACCTT GGGGANCAGGGAATTATGTGAGCTGATAGAGAGAA TTCAAATGCCTAAAGATCAAGGACAGTCACTGTGAC ACCCCTACTCCATNTCCAGCCCTACCNGGGAATCT GGGGGCCCTGACCTCTGCCTTCTGGGGGGGGCCC CTGTGATCCCATCGATGTCNACNCCAGTCTCATTCA GCCACGGTCTCTCCTAGCAACGGTT 8 Fgf3 ENSMUSG00000031074 AGCGNCNAAAGGCTTTGGNAACCNNNCCACCTTGN GNAAAGGGAATTATGTGAGCTNTNCGAGAGAATTC AAATGCCTAAAGTATCAAGGACAGTCACTGTGACA CCCCTACTCCATGTCGAGCCCTACCAGGGCATCTG TGGGCCCTGACCTCTGCCTTCTTGGTGGTGTCCCT GTGTTCCAGGTCCTCCCCGCACCCCCAGCTCCTCA CCCAGCACAGCCAGTGGAGCATCTTTTCCTGCTCA CAGTATTGACTAAGACAAAACAAACCACAGGACAG CCTGAAATGGCTGCCCAGACACGGGCTTTCCTTGT CCAATCCGGCAACTTGCAGACGGTCTCTCCT 11 Fgf3 ENSMUSG00000031074 AGAGGGACAGTNTCAGGCCTGTTGATC 14 Fgf3 ENSMUSG00000031074 TCTAGTAGGCTTCGTAAGCCTTGCGAACCAGAATTA AGGCTGAGCTTTTTGGGGGTGATC 15 Fgf3 ENSMUSG00000031074 GTGAACAAGGTACTTTGGAACCCCTCCACCTTGAT CAACAGGGATTATGTGAGCTNTCTAGAGAGAATTC ANATGCCTAAAGATCAAGGACAGTCACTGTGACAC CCCTACTCCATGTCNCAGCCCTACCAGGGCATCTG TGAGGCCCTGACCTCTGCCTTCTTGGTGGTGTCCC TGTGATCCCATCGATGTCGACACCAGTCTCATTCAG CCACGGTCTCTCCTAGCAACGGTTACTCTA

17 Fgf3 ENSMUSG00000031074 ATATGAACCTGTGGAAAAGCCATAGGCATTCTCTTG ATTAACGGCTGGTGTGGGAGGGCCGGGCCCTGCA CACTGTGGGAGCTGGCAATCCCCAAAGCAGACTGT AGCAAGCCATGAGGAGCAAGCCAGTGAGCAGTGC TCCTCTGTGCCTCTGCATCAGCTCCTTTCTCTAGCT TCCTGCTTTGAGTTCCTGCCCTGACCTCCCTAAGTG TGACTTGTGACCTGGGAGTTATCTCTGATC 18 Fgf3 ENSMUSG00000031074 GNTGAACNGAGNCACGTTNGGGAACGCTCNCGNC CTGNGAGGANATNGCGTGTNATTCATCGCNGNAGT CTGTTGNNGCAGNAGGANTATGAGAANGCCTGGAG AGATCCATNGCACGAGCTCCACATGGGGGCACAAT CGCCATGCATCTCACTGATANACGNTCCTACCAGG GGATAGNGGTGNTCNTCCTGGACCTCGTGCCTCTC TAGGTGGTGTCCCTGTGATCCCATCGATGTCGACA CCAGTCTCATTCAGCCACGGTCTCTCCTAGCAACG GTTACTC 22 Fgf3 ENSMUSG00000031074 AGGCATSTGCCCTTTGTCCTCAGTNGGCTAGGACT GACTTAAGCATCCTTCATTTGAGTCCCTGGGCCTTT GCCTCTGGTACTGCATGGGTGCTACTCTAAAGCCC AGGCTCCAGTTCAGTGGAGCCTTTCCTGCTTGTTG TGGGGACCAGCCAGACACCCTCCACAGGTGCAGT GGTGCAACATGGGAGATGAGGAAGGACCACACCA GGGTGCAGGTGGACTTTTTCAGCCAGCCTAGGACC ATGAATGGCAATGGTGTGTCTTCATACACAGTACAG GTAGGTTCTAAGTCCCATCCACACCCACATGAGGT AGAGTGAACTCTCCCCAAGTTCAACGGCTACATCC TGTGGGCTCTTGATC 33 Fgf3 ENSMUSG00000031074 GATGACACAGCCGCAGTCATGTCTGTCACTGTAGT GGGGACATTGAGGCACCAGAGACAGGCCACAGCC AAGGCTAGCTGTATGATC 35 Fgf3 ENSMUSG00000031074 GATGACACAGCCGCAGTCATGTCTGTCACTGTAGT GGGGACATTGAGGCACCAGAGACAGGCCACAGCC AAGGCTAGCTGTATGATC 40 Fgf3 ENSMUSG00000031074 GGTTTCTCTCTGGATAATGAGGTTNNGCNCCAGGG AAANGGTGCAGGNGTTCNTCCCCGGCCCTGNGGA GGGAAAGAGCGCTGTAGGATTCTGGAGGACAGNG CTGGTCCTATGGCCCCTTCAGTTGCCACCTGACTC CCAATGCCTCAGTTCAGCCTTAAGCACTGGATCAAT GGCCAAGGTTTGCCGACTTGGGATCCCATCGATGT CGACACCNGTCTCATTCAGCCACGGTCTCTCCTAG CAACGGTTACTCTAA 41 Fgf3 ENSMUSG00000031074 AACTTTGTTGGANTTCCAGGNCCTNNGGCTAGNAA GCAGGGCTGGCAGCTGCCATTGCTGNACCCCCAG CAAAGGCCACAGATACCTCTGCAGGCACCGCAGTT GCCTCCAGCCTAAGGACCTCTTGAGCTCANCCCAT TGCCACANAATCCAGGGNTCAAAGGATTTGAGATN TGACAGTAGAACTATGNNGGCCAATTAGCTACCTT GNGCATGGAGCATCCATGTCCNGGGTGGCCCCNN GTTCCCTCTGG 44 Fgf3 ENSMUSG00000031074 ATCGATGGNATCCANNAGNNGGGGTACAATGCAGA GCGCTGTAGCGTANGTACCAAGCACTCCCNAGAGN GTCCATACANCTTAGACNNAGACGCNGCCNCNGCA CGAGNCNTTCGGCACCAAGNCANGANNCAGTNTAG CGCNCANNCCNGTGCGAGCCCATCANAGANNGGC CGCACACAAAAGTCCTCTCTCTTCCTGCCNCGAGT CTNNTCCACAAGGACCATGAGATGGTGCGGCTGTT GCAGAGTAGCCNGCCACNAGCCCCANGAGAGGGC AGCCAGNCCAGGCATGCCNGTTNAGAAGAAGC

50 Fgf3 ENSMUSG00000031074 AGGCATSTGCCCTTTGTCCTCAGTNGGCTAGGACT GACTTAAGCATCCTTCATTTGAGTCCCTGGGCCTTT GCCTCTGGTACTGCATGGGTGCTACTCTAAAGCCC AGGCTCCAGTTCAGTGGAGCCTTTCCTGCTTGTTG TGGGGACCAGCCAGACACCCTCCACAGGTGCAGT GGTGCAACATGGGAGATGAGGAAGGACCACACCA GGGTGCAGGTGGACTTTTTCAGCCAGCCTAGGACC ATGAATGGCAATGGTGTGTCTTCATACACAGTACAG GTAGGTTCTAAGTCCCATCCACACCCACATGAGGT AGAGTGAACTCTCCCCAAGTTCAACGGCTACATCC TGTGGGCTCTTGATC 52 Fgf3 ENSMUSG00000031074 TTNCCNNNNAAGGGGGNATTGCANCAANNGCANCA NCNGTNTGANTCATCCNCNTTTCGCTTGTCTAGGG NTTGGCTGTCCTTTCCTGGGGCTNGNGGCTGGCTA CTNTGCAGCAAGNCCGCACCATCTNATGGNCCTTN NGGCCCANCACTNGGNGCAGGAAGANAGAGNNCT TTTGNTNCGTTGGNTCTTNAAGNCCCTGNNNNGCG ACCCTTGCCATTNANCGACACNTCCAAGGNNTTTG GNACCA 65 Fgf3 ENSMUSG00000031074 GACAAGGTACTTTGGGAACCNGGCACCTTGTCGCC AGGGATTATGTGAGCTGATAGCAGAGAATTCANAT GCCTAAAGATCAAGGACAGTCACTGTGACACCCCT ACTCCATGTCGAGCCCTACCAGGGCATCTGTGGGC CCTGACCTCTGCCTTCTTGGTGGTGTCCCTGTGAT C 66 Fgf3 ENSMUSG00000031074 GAAGATTGGCTCGTGACCCTGACTCTCAAGGATGA CACTGAGCTGGCTTGCCAGATGTGATC 70 Fgf3 ENSMUSG00000031074 GGTACTTTTTCAGCCAGCCTAGGNACCATGAATGG NAATGGTGTGTCTTCATACACAGTACAGGTAGGTTC TAAGTC 80 Fgf3 ENSMUSG00000031074 GTGCTNCCACCATCNGNAGGAGAGACTTCTGTCAC CTTGNAATAGTCAGAGCTCTGTATGAGAGTCCCTG GGCTATCAAGTGTGTTTTATGGGAGTCACAGTACCT CATACTGAGCACTGGAGTCTTAGTCCTCTGAGGTC 85 Fgf3 ENSMUSG00000031074 AGCGCGCAGGGGTGTTGGGGGGATNNCATCGACC NGAAAATTCTCTTTTTACTCTAATGCCCACCGTACC CCATTGTCTTTGCAACAAAAATAACTCGTGTTCCCC ATGCAATGACTTTCTTNCCATCGATGTCGACACCAG TCTCATTCAGCCACGGTCTCTCCTAGCAACGGTTAC TCTA 86 Fgf3 ENSMUSG00000031074 CCCTCAGAGGCNCCNANTCTCTANANGCNTGCTGC GTNNNCTGAGACCCCTTTGNCGTGAGGGGGATCTA AATGTACCCTTTTACTGATC 87 Fgf3 ENSMUSG00000031074 GCGTGGGGCAGAGACCCTGTTNCNNCCTGGCNAG AAACAGAGGCCCTGGGAGATCCTTGAGGGTGCTCA GCTGTGGAGAGACATGTGCATTCAGCATGCTGAAG AGGGCCTGCTACCCTAAATGAGGTTCTCAGGGTGG AAAATGTCCCAGTGTGTGCTAGTAATAGCTTCTGTA TCGTGGAGGTCCCCCCACCCCAACACTTCTCAGGA TCCCATCGATGTCGACACCAGTCTCATTCAGCCAC GGTCTCTCCTAGCAACGGTTACTCTA 91 Fgf3 ENSMUSG00000031074 ATCTTGAACTTCGAGTCTTCCAGAGTCTCTGACTCA AGCCCCTTAGCAGCTGGAACTTGCTCTTTGAAAGC TGTAAAAGGCATGCAA 96 Fgf3 ENSMUSG00000031074 ACACCCGTGTGTGGGTCACTTGTGAAGCTCTGTCT GTGGACAAAAGTSTCTGTCTCAGAGATGGACCCAG GATC 98 Fgf3 ENSMUSG00000031074 GGTGGGCCTGNGGGGGTGACATCCGCCAATTTGN AAAGGTCAGGGAGGCCACTCCTCCTCCCAGGATGA GATCCCATCGATGTCGACACCAGTCTCATTCAGCC ACGGTCTCTCCTAGCAACGGTTACTCTA

103 Fgf3 ENSMUSG00000031074 GGGTGGGACCTTTTNTGATACCTCAGGAAGTCCTT NTTCTTTGAGGCCCTTGGCAGATAAGGAACTGAGG TCAAGAGCTCAGGGTCCAGGGAGCTATTCCCTGAA CCTGGNCTCTCCCCTNTCAGCCTNCCANGTGGTGT CATNCNGTGCNCACATTGTGGGATC 104 Fgf3 ENSMUSG00000031074 AGGCCTANGTTGTACATAACAATCTTNNGGCTGCG CTAGAGAANCNTAGCACGCTCTCCTGCTATTCCAG GTCANCTATNATCAGNAACCTGAGCACTGTGCTGT GCCTTTGTTGATAAGCTCCTTGGCAGCAATTAACAG CACTGAGCCATAAGTGAGGCAGGGCAGCCTTCACA CATGCTCTTGACTGAGAATAGGCAAGCCTGCAGGA GCTGCACAGCAAATACCCAGCCTGCATCTCCCCTT CACTCTGCATCAGCCTTGGGCCAGGCTGGATC 106 Fgf3 ENSMUSG00000031074 TGCTGCAGGCGCGGCATTTACAGCTGGGTACATGC CTTTAATCACAGCACTCAGGAGGCAGGGTCAGGCA GATC 133 Fgf3 ENSMUSG00000031074 TAANTNTNNGGCNCGGCGCGGCNTGTACTTTCTGT CCCCTTGAGGGCAAGGGTTATGTTCTCCTTCCCCA GAACCATGATCCCATCGATGTCGACACCAGTCTCA TTCAGCCACGGTCTCTCCTAGCAACGGTTACTCNA AANNCNNGGGGGNTGANGNGANAANAANATTTTNT GCTGNAGGNNCGGCANTGANNTATCTGTCCCCNTA AGANAAGGATNATNTTCTCCTTCCCCAAAGNCGTG ATCCGAGCGNNTTCCANCCATANGATTANACCTGT GTCTCTCNGTTCTNTAAA 111 PT Fgf3 ENSMUSG00000031074 TCCTCTGTGCCTCTGCNATCTNNNCCTTTCTCTGAA TTCCTGCTTTGAGTTCCTGCCNTGANCTNCCTAAGT GTGACTTGTGACCTGGGTAGTTATCTCTGATCTTGG TGTTCATCACAGCAACAGAAGAACACTGGAGCAAC TTACTGTGTGGTCTTGTGTTGGCATCTCTGATCCTT CTCTGGAANATGTGATAACNACCCTGACTTGTTTCC CC 128 PT Fgf3 ENSMUSG00000031074 TTGGGGTNCAGGTAGNAAAGCCACCAGGAACACAC AGTGTTAAACTGTGGTGAGGGCTAGATTCAAAGCT CCTAAAGCCATCCTTGAAACCCCTCTCCATCCAGTG CTTTTANGATGATGAATCACTGGAGNCCCCTGTCCT CAGNTTCCATCTCTGCCTGCCGCTGTCCACGTGGN CCCGGTG 135 PT Fgf3 ENSMUSG00000031074 GCTCCAGCTTCAGCATGGANCCTCTCGAATTTCACT CAAGCGATAGCGTCTCTCAACAGAGGTGGACATCT GTATGCAAGAGTTTCNGCACCTGTGGTCCTGGCGT GA 140 PT Fgf3 ENSMUSG00000050917 CTTGAGGGTCACCAGGAGAACACACAGGATGATAA GGGCAAAGCCCCAGGTTCACACAAAAACTCTTCAT CTGCCCACTGAGTTCATGAGCATTAGGGTATGCTT AAATAGGGATTCATATCTGGGTGTGGCAGCTCACT CCTTTAATCCCAGTACTTGGGAGGCNGAGGCNGGT GATC 144 PT Fgf3 ENSMUSG00000031074 CCTGGGTGTCTCCCTAGGCCAGAAGATAGTGTCTG ATC 161 PT Fgf3 ENSMUSG00000031074 GGAAGTATTTATGAGGGGGCNGGGTGNAAGGGTA TTTGGGGGTCTGGCCCTGGGAAGCTGGAGCCAGC ATGATC 173 PT Fgf3 ENSMUSG00000031074 GCCAGGATGTCNTTCCCACNGCGTGCNCCAGNTGC TTGCGCGCCTACTCTAGTTTTAGGGGAGAAGCAGG NTAGAAAGGGGTCTTGTGATC 174,2 PT Fgf3 ENSMUSG00000031074 AAACACAGAGCTAGGCCTGGNGGCAGGAATAAATG GCCCACGGATTGATC 177 PT Fgf3 ENSMUSG00000031074 GGTATAGCTAAGGCATGAAGAGATTAGTGTCACCA ACTAGGTGACAAGTGGCAGAGGCAGCCCCCTGGC CAGCATCTGGTTGGTAGTCAGAGATAAGAGGGTAC GTGATGC

191 PT Fgf3 ENSMUSG00000031074 GGCAGGAAGGAGCTGAGTTCAGGCAGNAAGTCCT CGCCAGCTGCTGATGATTATGGTGAACTTGGTCTG GGCCGTGCCAGAGTCACTGTGAACACCGAGGAAA AANAACCAAGNGCCTGAAANAGCNGNCNNATCTNC ATATNNTACNCCATTC 96 PT Fgf3 ENSMUSG00000031074 AGACAACTGGATGNAGGAGGNATTTTTCGCCGGCC TAGACTATGNCAGGCATNTGGTGAGAACTTGCATA CANAGTCACNTGNAGGTTCTAAGTCCCATCCACAC CCACATGAGGTNGAGTGTAACTCTCCCNAAGTTCA ACGGNTACNTCCTG 72 Fgf3 ENSMUSG00000031074 CAGGTCCACATGGNAATCTCACTGNCTGGAATGCT CTGAAATGTCTATGTGCCTCCCCATGGGGCTTGTG TGCGTGTGTGTGTCCCAGCCTACAGCCAAATTTCTT CATCAGGACACTAATGGCTGATC 14 Fgf4 ENSMUSG00000050917 GGGTCTCCTGGTAATCAGTGATCTACCTGCCTCTG CATTCCTAATGCCGGGATTAAAGGAGTGCACCACA GGGCCTGGTGATC 82 Fgf4 ENSMUSG00000050917 GTTGGGCNATGCCTGCTAACCTTAGCTCCTAGGNA AATGGNGNCANGTAGGCATCAGAAATTCAAGGTCA TCTTTAGATGACATACGTCACAGTTCAGGTACAGAC CTGTGGCTATGAGACCGTCTTTTAGGAAAATAACAA GAAGAAAAGACATTTCAACTGTCTTCTCCCCAACAC TCTTGGAGCCTAGGGCCTGGATTTCCATCGATGTC GACACCAGTCTCATTCAGCCACGGNCTCTCCTAGC AACGGTAACTCNA 71 Fgf6 ENSMUSG00000000183 CCTAAGGGTTTTTTTTGCCCCAGATCCTACATAAAA AAGCTGGGTGTGGTGACATGTGCTTGTAATGCCCA GGATC 76 Fgf6 ENSMUSG00000000184 TGTNTTGTGCAAGGCTGCGCCAGTGCCTGGCAAAC ACAGAAGTAGATGCTCANAGTCATCTATTGGATGG AACANAGGGCCCCCCAATGGAGGAGCTCGAGAAA GNACCCAAGGAGCTGAGTGAGGTG 95 Fgf6 ENSMUSG00000000183 TCATCACTNTGTCCCGGGGAGCAGGACGTGTTCAG GGCACGCTGCAGGCTCTCGTCTTCTTAGGCGTCCT AGTGGGCATG 4 Fgf8 ENSMUSG00000025219 CAGTGGGACTGTAAAAGTGCTATTGCCTGCCAAAT CACTGACAGGATAAAAGCTACCATCGGTTGGCAGG TGAAGCCACCAAAGGTGGAAGATAGTCTAATGGCT CAGTCAGGTGGCCCCCATCCATCCATCCAACACTA CCTGCAGAGCTACAGCTCTGCCCTGAGCTTTGATC 58 Fgf8 ENSMUSG00000025219 TCCNATCCTCCTCCTTCAGAAAGGCAGGGGACAGA ACACCACCGTCTCCATGCCGGTGTGATGATGACTC GTGTGAAAAGCCGAAAGGGAGCCTGGGAAGAGAG AAGAGCAGGGGCACAGGTGCCCCGGACAGAAGAG GAGGGCAGGTTTCCTGAGTGGTAGCCTGATC 94 Fgf8 ENSMUSG00000025219 GNTCTGNNNCATNGCATATTCTGGGCTACCACATG CATGGNAGGCCTGTGGTNGGCCAAAGCNAGTCTG ATC 97 Fgf8 ENSMUSG00000025219 CATTCAGNAANCAGAAACATTAGNTNNCTGCTCCC GAAAANNTCAAGCAGCGACAGTACNCNGGCCCTTT TNAGCTCTTGAGCTCATTTGGCTCATTTTTGTCTCC TGGCTCTTANNCCCTCAACTAACAAACCGCACCTCA CTTATGGGTGACCTTGAAGCCACTCTCCCTCCTAG AGCTGCTACATCGCATCCCGTCACAGGANATCTGC TGGCAGCTCAGGATCCCATCGANGTNNACACCNGG CNCATTCACCCCCGGTCTCTCCNNGCAANGGNNNC TCTA